Track market-moving stories before they get noisy

BEIJING, Sept. 09, 2026 (GLOBE NEWSWIRE) -- 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading AI-powered application service provider focused on personalized learning solutions, today announced its unaudited financial results for the second quarter of 2026.

Second Quarter 2026 Highlights1

Net revenues were RMB90.1 million (US$13.3 million), compared with net revenues of RMB25.4 million in the second quarter of 2025.Gross margin was 69.2%, compared with 57.5% in the second quarter of 2025.Net income was RMB1.1 million (US$0.2 million), compared with net loss of RMB26.0 million in the second quarter of 2025.Net income as a percentage of net revenues was 1.2% in the second quarter of 2026, compared with negative 102.1% in the second quarter of 2025.Adjusted net income (non-GAAP), which excluded share-based compensation expenses of RMB3.6 million (US$0.5 million), was RMB4.7 million (US$0.7 million), compared with adjusted net loss (non-GAAP) of RMB18.9 million in the second quarter of 2025.Adjusted net income (non-GAAP) as a percentage of net revenues was 5.2% in the second quarter of 2026, compared with negative 74.3% in the second quarter of 2025. First Half 2026 Highlights1

Net revenues were RMB189.5 million (US$27.9 million), compared with net revenues of RMB47.1 million in the first half of 2025.Gross margin was 65.4%, compared with 47.7% in the first half of 2025.Net loss was RMB18.3 million (US$2.7 million), compared with net loss of RMB56.9 million in the first half of 2025.Net loss as a percentage of net revenues was negative 9.6% in the first half of 2026, compared with negative 120.9% in the first half of 2025.Adjusted net loss (non-GAAP), which excluded share-based compensation expenses of RMB7.8 million (US$1.2 million), was RMB10.4 million (US$1.5 million), compared with adjusted net loss (non-GAAP) of RMB41.3 million in the first half of 2025.Adjusted net loss (non-GAAP) as a percentage of net revenues was negative 5.5% in the first half of 2026, compared with negative 87.7% in the first half of 2025.     1For a reconciliation of non-GAAP numbers, please see the table captioned “Reconciliations of non-GAAP measures to the most comparable GAAP measures” at the end of this press release.
Mr. Andy Liu, Founder, Chairman and Chief Executive Officer of the Company commented, “We are pleased to report another quarter of strong progress, with net revenues increasing 254.6% year over year and both GAAP and non-GAAP profitability achieved for the first time. More importantly, these results further validate our strategic transformation into an AI-powered application service provider and demonstrate the scalability and operating leverage of our evolving business model.”

“As we continue to extend our AI capabilities across the education ecosystem, we recently introduced a dedicated AI agent for teachers, designed to support key teaching workflows, including assessment, content generation and learning analytics, building upon our district-level AI agent initiatives and student-facing personalized learning services. Together, our district-level, teacher-facing and student-facing AI applications are forming an interconnected ecosystem spanning education administration, teaching and personalized learning. Going forward, we will continue to leverage AI to enhance our products and internal workflows, improve operating efficiency and support healthy, sustainable growth,” he added.

Ms. Sishi Zhou, Chief Financial Officer of the Company, commented, “Our second-quarter results underscore the improving economics of our evolving business model. Gross margin expanded to 69.2%, while continued revenue growth and disciplined cost management enabled us to achieve our first quarterly GAAP net profit. We are particularly encouraged that this improvement was achieved while continuing to invest in AI capabilities and product innovation.”

“With a cash position of RMB456.9 million as of quarter end, we maintain a strong financial position to support continued investment in innovation and long-term growth. We will remain disciplined in capital allocation as we balance growth investments with our commitment to sustainable profitability and long-term shareholder value creation.”

Second Quarter 2026 Unaudited Financial Results

Net Revenues

Net revenues for the second quarter of 2026 were RMB90.1 million (US$13.3 million), representing a year-over-year increase of 254.6% from RMB25.4 million in the second quarter of 2025. The substantial revenue growth was primarily driven by the continued expansion of Yiqi Aixue, the Company's consumer-facing AI application service, together with ongoing contributions from district-level and school-based projects.

Cost of Revenues

Cost of revenues for the second quarter of 2026 was RMB27.8 million (US$4.1 million), representing a year-over-year increase of 157.2% from RMB10.8 million in the second quarter of 2025, which was mainly due to the increased related service delivery costs, driven by the continued growth of Yiqi Aixue.

Gross Profit and Gross Margin

Gross profit for the second quarter of 2026 was RMB62.3 million (US$9.2 million), compared with RMB14.6 million in the second quarter of 2025.

Gross margin for the second quarter of 2026 was 69.2%, compared with 57.5% in the second quarter of 2025, representing an improvement of 11.7 percentage points. The increase in gross margin was primarily attributable to the growing contribution of Yiqi Aixue, the Company's consumer-facing AI application service and the continued optimization of the Company's revenue mix.

Total Operating Expenses

The following table sets forth a breakdown of operating expenses by amounts and percentages of revenue during the periods indicated (in thousands, except for percentages):

  For the three months ended June 30,   2025  2026     Year-   RMB  %  RMB  USD  %  over-year Sales and marketing expenses  13,995   55.1%  26,894   3,964   29.9%  92.2%Research and development expenses  12,002   47.2%  20,025   2,951   22.2%  66.8%General and administrative expenses  17,066   67.2%  16,032   2,363   17.8%  -6.1%Total operating expenses  43,063   169.5%  62,951   9,278   69.9%  46.2%
Total operating expenses for the second quarter of 2026 were RMB63.0 million (US$9.3 million), including RMB3.6 million (US$0.5 million) of share-based compensation expenses, representing a year-over-year increase of 46.2% from RMB43.1 million in the second quarter of 2025.

Sales and marketing expenses for the second quarter of 2026 were RMB26.9 million (US$4.0 million), including RMB1.1 million (US$0.2 million) of share-based compensation expenses, representing a year-over-year increase of 92.2% from RMB14.0 million in the second quarter of 2025. The increase was primarily attributable to increased sales and marketing investment activities in support of the continued expansion of Yiqi Aixue.

Research and development expenses for the second quarter of 2026 were RMB20.0 million (US$3.0 million), including RMB0.9 million (US$0.1 million) of share-based compensation expenses, representing a year-over-year increase of 66.8% from RMB12.0 million in the second quarter of 2025. The increase in research and development expenses was primarily attributable to higher personnel-related costs associated with research and development activities to support a broader range of AI application scenarios.

General and administrative expenses for the second quarter of 2026 were RMB16.0 million (US$2.4 million), including RMB1.5 million (US$0.2 million) of share-based compensation expenses, representing a year-over-year decrease of 6.1% from RMB17.1 million in the second quarter of 2025. The decrease was primarily attributable to lower share-based compensation expenses and disciplined cost management.

Loss from Operations

Loss from operations for the second quarter of 2026 was RMB0.6 million (US$0.1 million), compared with RMB28.5 million in the second quarter of 2025. Loss from operations as a percentage of net revenues for the second quarter of 2026 was negative 0.7%, compared with negative 112.0% in the second quarter of 2025.

Net Income (Loss)

Net income for the second quarter of 2026 was RMB1.1 million (US$0.2 million), compared with net loss of RMB26.0 million in the second quarter of 2025. Net income as a percentage of net revenues was 1.2% in the second quarter of 2026, compared with negative 102.1% in the second quarter of 2025.

Adjusted Net Income (Loss) (non-GAAP)

Adjusted net income (non-GAAP) for the second quarter of 2026 was RMB4.7 million (US$0.7 million), compared with adjusted net loss (non-GAAP) of RMB18.9 million in the second quarter of 2025. Adjusted net income (non-GAAP) as a percentage of net revenues was 5.2% in the second quarter of 2026, compared with negative 74.3% of adjusted net loss (non-GAAP) as a percentage of net revenues in the second quarter of 2025.

Please refer to the table captioned “Reconciliations of non-GAAP measures to the most comparable GAAP measures” at the end of this press release for a reconciliation of net loss under U.S. GAAP to adjusted net loss (non-GAAP).

Cash and Cash Equivalents, Restricted Cash and Term Deposits

Cash and cash equivalents, restricted cash and term deposits were RMB456.9 million (US$67.3 million) as of June 30, 2026, compared with RMB407.0 million as of December 31, 2025.

Conference Call Information

The Company will hold a conference call on Tuesday, September 8, 2026 at 9:00 p.m. U.S. Eastern Time (Wednesday, September 9, 2026 at 9:00 a.m. Beijing time) to discuss the financial results for the second quarter of 2026.

Please note that all participants will need to preregister for the conference call participation by navigating to https://register-conf.media-server.com/register/BI6a9b3074492c49129db706c4d4bc5622.

Upon registration, you will receive an email containing participant dial-in numbers, and PIN number. To join the conference call, please dial the number you receive, enter the PIN number, and you will be joined to the conference call instantly.

Additionally, a live and archived webcast of this conference call will be available at https://ir.17zuoye.com/.

Non-GAAP Financial Measures

17EdTech’s management uses adjusted net income (loss) as a non-GAAP financial measure to gain an understanding of 17EdTech’s comparative operating performance and future prospects.

Adjusted net income (loss) represents net income (loss) excluding share-based compensation expenses, and such adjustment has no impact on income tax.

Adjusted net income (loss) is used by 17EdTech’s management in its financial and operating decision-making as a non-GAAP financial measure, because management believes it reflects 17EdTech’s ongoing business and operating performance in a manner that allows meaningful period-to-period comparisons. 17EdTech’s management believes that such non-GAAP measure provides useful information to investors and others in understanding and evaluating 17EdTech’s operating performance in the same manner as management does, if they so choose. Specifically, 17EdTech believes the non-GAAP measure provides useful information to both management and investors by excluding certain charges that the Company believes are not indicative of its core operating results.

The non-GAAP financial measure has limitations. It does not include all items of income and expense that affect 17EdTech’s income (loss) from operations. Specifically, the non-GAAP financial measure is not prepared in accordance with GAAP, may not be comparable to non-GAAP financial measures used by other companies and, with respect to the non-GAAP financial measure that excludes certain items under GAAP, does not reflect any benefit that such items may confer to 17EdTech. Management compensates for these limitations by also considering 17EdTech’s financial results as determined in accordance with GAAP. The presentation of this additional information is not meant to be considered superior to, in isolation from or as a substitute for results prepared in accordance with U.S. GAAP.

Exchange Rate Information

The Company’s business is primarily conducted in China and all of the revenues are denominated in Renminbi (“RMB”). However, periodic reports made to shareholders will include current period amounts translated into U.S. dollars (“USD” or “US$”) using the exchange rate as of balance sheet date, for the convenience of the readers. Translations of balances in the consolidated balance sheets and the related consolidated statements of operations, comprehensive loss, change in shareholders’ equity and cash flows from RMB into USD as of and for the three months ended June 30, 2026 are solely for the convenience of the readers and were calculated at the rate of US$1.00=RMB6.7851 representing the noon buying rate set forth in the H.10 statistical release of the U.S. Federal Reserve Board on June 30, 2026. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into US$ at that rate on June 30, 2026, or at any other rate.

About 17 Education & Technology Group Inc.

17 Education & Technology Group Inc. is a leading AI-powered application service provider in China, focused on personalized learning solutions. Leveraging over a decade of large-scale, longitudinal educational insights accumulated from daily teaching and learning interactions across diverse scenarios, alongside deep user engagement, and advanced AI capabilities, the Company develops application services that help students learn more effectively, empower educators, and drive innovation across the education ecosystem.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about 17EdTech’s beliefs and expectations, are forward-looking statements. 17EdTech may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: 17EdTech’s growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users; its ability to carry out its business and organization transformation, its ability to implement and grow its new business initiatives; the trends in, and size of, China’s online education market; competition in and relevant government policies and regulations relating to China's online education market; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in 17EdTech’s filings with the SEC. All information provided in this press release is as of the date of this press release, and 17EdTech does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

17 Education & Technology Group Inc.
Ms. Lara Zhao
Investor Relations Manager
E-mail: [email protected]

17 EDUCATION & TECHNOLOGY GROUP INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands of RMB and USD, except for share and per ADS data, or otherwise noted)   As of December 31,  As of June 30,   2025  2026  2026   RMB  RMB  USD ASSETS         Current assets         Cash and cash equivalents  246,448   456,856   67,332 Restricted cash  49   —   — Term deposits  160,471   —   — Accounts receivable, net  42,577   24,342   3,588 Prepaid expenses and other current assets, net  101,135   78,631   11,589 Total current assets  550,680   559,829   82,509 Non-current assets         Property and equipment, net  22,455   19,187   2,828 Right-of-use assets  15,003   12,541   1,848 Other non-current assets  2,385   2,364   348 TOTAL ASSETS  590,523   593,921   87,533 LIABILITIES         Current liabilities         Accrued expenses and other current liabilities  123,280   135,109   19,913 Deferred revenue and advances from customers, current  165,939   176,513   26,015 Operating lease liabilities, current  4,992   4,507   664 Total current liabilities  294,211   316,129   46,592    As of December 31,  As of June 30,   2025  2026  2026   RMB  RMB  USD Non-current liabilities         Operating lease liabilities, non-current  9,684   7,568   1,115 TOTAL LIABILITIES  303,895   323,697   47,707 SHAREHOLDERS' EQUITY         Class A ordinary shares  256   256   38 Class B ordinary shares  140   140   21 Treasury stock  (42)  (43)  (6)Additional paid-in capital  11,126,837   11,134,106   1,640,964 Accumulated other comprehensive income  77,527   72,107   10,626 Accumulated deficit  (10,918,090)  (10,936,342)  (1,611,817)TOTAL SHAREHOLDERS' EQUITY  286,628   270,224   39,826 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  590,523   593,921   87,533  17 EDUCATION & TECHNOLOGY GROUP INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands of RMB and USD, except for share and per ADS data, or otherwise noted)   For the three months ended June 30,   2025  2026  2026   RMB  RMB  USD Net revenues  25,410   90,092   13,278 Cost of revenues  (10,798)  (27,772)  (4,093)Gross profit  14,612   62,320   9,185 Operating expenses (Note 1)         Sales and marketing expenses  (13,995)  (26,894)  (3,964)Research and development expenses  (12,002)  (20,025)  (2,951)General and administrative expenses  (17,066)  (16,032)  (2,363)Total operating expenses  (43,063)  (62,951)  (9,278)Loss from operations  (28,451)  (631)  (93)Interest income  2,248   1,686   248 Foreign currency exchange loss  (44)  (21)  (3)Other income, net  301   72   11 (Loss) income before provision for income tax  (25,946)  1,106   163 Income tax expenses  (6)  —   — Net (loss) income  (25,952)  1,106   163 Net (loss) income available to ordinary shareholders  (25,952)  1,106   163 of 17 Education & Technology Group Inc.         Net (loss) income per ordinary share         Basic  (0.06) ­­0.00  0.00 Diluted  (0.06) 0.00  0.00 Net (loss) income per ADS (Note 2)         Basic  (3.00) 0.10  0.02 Diluted  (3.00) 0.09  0.01 Weighted average shares used in calculating net (loss) income per
ordinary share         Basic  461,000,966  542,476,566  542,476,566 Diluted  461,000,966  582,168,348  582,168,348           Note 1: Share-based compensation expenses were included in the operating expenses as follows:             For the three months ended June 30,   2025  2026  2026   RMB  RMB  USD Share-based compensation expenses:         Sales and marketing expenses  1,929   1,118   165 Research and development expenses  2,872   939   138 General and administrative expenses  2,261   1,536   226 Total  7,062   3,593   529           Note 2: Each one ADS represents fifty Class A ordinary shares.          17 EDUCATION & TECHNOLOGY GROUP INC. Reconciliations of non-GAAP measures to the most comparable GAAP measures (In thousands of RMB and USD, except for share, per share and per ADS data)     For the three months ended June 30,   2025  2026  2026   RMB  RMB  USD Net (loss) income  (25,952)  1,106   163 Share-based compensation  7,062   3,593   529 Income tax effect  —   —   — Adjusted net (loss) income  (18,890)  4,699   692  17 EDUCATION & TECHNOLOGY GROUP INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands of RMB and USD, except for share and per ADS data, or otherwise noted)   For the six months ended June 30,   2025  2026  2026
   RMB  RMB  USD Net revenues  47,078   189,544   27,935  Cost of revenues  (24,633)  (65,643)  (9,675) Gross profit  22,445   123,901   18,260  Operating expenses (Note 1)         Sales and marketing expenses  (27,008)  (70,095)  (10,331) Research and development expenses  (24,594)  (36,212)  (5,337) General and administrative expenses  (33,167)  (39,519)  (5,824) Total operating expenses  (84,769)  (145,826)  (21,492) Loss from operations  (62,324)  (21,925)  (3,232) Interest income  4,924   3,459   510  Foreign currency exchange loss  (111)  (30)  (4) Other income, net  621   244   36  Loss before provision for income tax and income from
equity method investments  (56,890)  (18,252)  (2,690) Income tax expenses  (6)  —   —  Net loss  (56,896)  (18,252)  (2,690) Net loss available to ordinary shareholders of 17  (56,896)  (18,252)  (2,690) Education & Technology Group Inc.         Net loss per ordinary share         Basic and diluted  (0.12) (0.03) (0.00) Net loss per ADS (Note 2)         Basic and diluted  (6.00) (1.68) (0.25) Weighted average shares used in calculating net income (loss) per
ordinary share         Basic and diluted  461,652,947  542,610,162  542,610,162            Note 1: Share-based compensation expenses were included in the operating expenses as follows:             For the six months ended June 30,   2025  2026  2026
   RMB  RMB  USD Share-based compensation expenses:         Sales and marketing expenses  4,022   1,965   290  Research and development expenses  5,269   2,631   388  General and administrative expenses  6,317   3,239   477  Total  15,608   7,835   1,155            Note 2: Each one ADS represents fifty Class A ordinary shares.          17 EDUCATION & TECHNOLOGY GROUP INC. Reconciliations of non-GAAP measures to the most comparable GAAP measures (In thousands of RMB and USD, except for share, per share and per ADS data)     For the six months ended June 30,   2025  2026  2026   RMB  RMB  USD Net Loss  (56,896)  (18,252)  (2,690)Share-based compensation  15,608   7,835   1,155 Income tax effect  —   —   — Adjusted net loss  (41,288)  (10,417)  (1,535)

Berkshire Hathaway's latest 13F reveals a stock portfolio far more concentrated than most investors realize, with the bulk of its equity weight sitting in just three consumer franchises that Buffett has held through recessions, bubbles, and every market cycle since…

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Warren Buffett’s Berkshire Hathaway (NYSE:BRK.B) filed its latest 13F for the quarter ended June 30, 2026, disclosed on August 14. The most striking feature of the disclosure was three names carry roughly half of the entire reported equity book by weight.

Those three are Apple (NASDAQ:AAPL | AAPL Price Prediction), American Express (NYSE:AXP), and Coca-Cola (NYSE:KO). All three are long-standing Buffett anchors (we sorted Berkshire’s holdings by valuation and pulled the seven cheapest dividend payers into a free report here: 7 Warren Buffett Stocks to Buy Now). All three are consumer-facing franchises with pricing power. And all three sit inside a disclosed portfolio that gets more concentrated the closer you look.

One critical framing point before the numbers: a 13F covers US-listed long equity only. It excludes Berkshire’s cash and Treasury holdings, its wholly owned operating businesses like BNSF, GEICO, and Berkshire Hathaway Energy, and any non-US-listed exposure. So these three names are roughly half of the disclosed stock portfolio, not half of Berkshire’s money, net worth, or fortune. Berkshire is a holding company, not a fund. Positions are shown as of quarter end and may have shifted since.

Apple: The Anchor Position Berkshire disclosed 227,917,808 shares of Apple at quarter end, representing 22.04% of the disclosed portfolio. Apple designs the iPhone, Mac, iPad, Wearables, and the fast-growing Services business that layers a high-margin subscription annuity on top of the installed base.

Buffett has publicly framed Apple less as a technology bet and more as a consumer franchise with switching costs, and the fundamentals support the read. Apple trades at a P/E of 42 with a ROE of 171.4% and ROIC of 53.3%. The June quarter delivered revenue of $109.42 billion, up 16.4% year over year, with EPS of $2.02 versus a $1.89 estimate, and Tim Cook called it the company’s “strongest June quarter ever, with double-digit revenue growth across iPhone, Mac and Services, and in every geographic segment.” Apple bought back $62.09 billion of stock in the first nine months of FY26, which mechanically lifts Berkshire’s ownership stake without a single share being traded.

Our 24/7 Wall St. model sees upside of 15.31% at high confidence (0.9), with a base one-year target of $368.95 from a current $319.97. Wall Street’s consensus target is more measured at $323.86, with 6 strong buy, 19 buy, 14 hold, 3 sell, and 2 strong sell ratings. Our model is meaningfully more constructive than the Street here, driven by sector momentum and earnings acceleration; the analyst community is closer to fair value. Predictions are as of publication; the 13F snapshot is as of quarter end.

American Express: The Longest-Running Bet Berkshire’s disclosed American Express stake stood at 151,610,700 shares, or 17.14% of the disclosed portfolio. American Express operates a closed-loop payments network and card business skewed to premium, high-spend customers.

This is the oldest of Buffett’s blue-chip anchors, and it keeps compounding. Q2 revenue reached $19.64 billion with EPS of $4.53 versus $4.40 expected, and CEO Stephen Squeri highlighted “another excellent quarter, with 10 percent revenue growth, EPS of $4.53, and Card Member spending growth of 9 percent, the highest rate we’ve seen in three years on an FX-adjusted basis.” Management raised full-year revenue growth guidance to 10% and maintained EPS guidance of $17.30 to $17.90. The quarterly dividend has climbed from $0.60 in 2023 to $0.95 in 2026, and diluted share count is running down.

Our model projects upside of 9.05% at high confidence (0.9), with a base target of $355.67 from $326.16. Interestingly, the Street is more optimistic than we are: consensus target is $375.96, with 5 strong buy, 10 buy, 14 hold, 1 sell, and 0 strong sell ratings. The disagreement is worth noting given AXP has fallen 11.12% year to date against a 33.94% run in Apple.

Coca-Cola: The Dividend Compounder The Coca-Cola position was disclosed at 400,000,000 shares, or 10.86% of the disclosed portfolio. That share count is a well-known constant of the Berkshire book, unchanged for many years, and it means Buffett’s original 1988 cost basis produces an enormous yield on cost as the dividend keeps climbing, from $0.16 per quarter in 1999 to $0.53 per quarter in 2026.

The business is executing. Q2 delivered revenue of $13.38 billion, up 6.74% year over year, EPS of $0.97 versus $0.93 expected, and global unit case volume growth of 5%. New CEO Henrique Braun described “a strong first half of the year” and said the company was “well positioned to deliver on our RAISED 2026 guidance”, which now calls for organic revenue growth of about 5% and comparable currency-neutral EPS growth of 7% to 8%. Trademark Coca-Cola volume grew 5% during the quarter, described as its strongest volume growth in 17 years excluding COVID recovery, helped by the FIFA World Cup activation across more than 180 markets.

Our model flags upside of 10.07% at high confidence (0.9), with a base target of $96.94 from $88.07. Bull and bear cases run to $101.34 and $85.15. Consensus is closely aligned at $94.70, with 7 strong buy, 12 buy, 4 hold, 0 sell, and 1 strong sell ratings. KO trades at a P/E of 29 with a 2.32% dividend yield. Shares are up 27.67% year to date.

What the Top Three Says About Buffett’s Approach Concentration is the story. Three tickers carrying 22.04%, 17.14%, and 10.86% of a disclosed equity book is the opposite of diversification for its own sake. The sector tilt is unmistakable: one consumer technology franchise, one premium payments network, and one global beverage brand. All three sell products with brand pricing power that survives inflation, recessions, and management changes. None of them are speculative; all three throw off cash and buy back stock. On holding period, this is the essence of the Buffett approach: the KO share count has not changed in decades, AXP has been core since the 1990s, and even Apple, added in 2016, is treated like a legacy holding rather than a trade. The absence of any hot theme, no AI pure-play, no crypto exposure, no highly cyclical bet, is itself the tell.

What to Watch Next Studying this book, the takeaway for a reader at or near retirement centers on the discipline behind them: fewer tickers to copy, more focus on process: fewer names, higher-quality businesses, and a willingness to sit still. The next 13F, disclosed roughly 45 days after the September quarter closes, will show whether these anchors moved at all, and the next earnings reports from all three names are the near-term catalysts. 13F disclosures are backward looking. Price predictions are projections, not guarantees. And none of this is investment advice.

Contact [email protected] for any questions or corrections.

Engineering Talent Moves In-House@Sei_Labs has acquired @bilinearlabs, bringing the firm's Rust-based engineering talent and data analytics capabilities directly into the $SEI ecosystem. The Bilinear team is transitioning into core development roles focused on Sei Network and the upcoming Sei Giga scaling initiative, deepening the in-house technical bench at a critical moment for the protocol.

The move follows Bilinear's track record of delivering real-time financial insights and on-chain intelligence for high-velocity decentralized markets, a profile that fits squarely with Sei's performance-first positioning in DeFi infrastructure.

What Is Sei Giga and Why Does It Matter?Sei Giga is @Sei_Labs' most ambitious technical undertaking to date. The initiative targets over 50x throughput, 70x faster block production, and 40x execution efficiency, with the broader goal of making Sei the first multi-proposer EVM Layer 1. It leverages parallel block proposals to solve bottlenecks, scaling the EVM with innovations across data availability, consensus, execution, and storage.

Key targets include 5 gigagas of throughput at roughly 200,000 transactions per second, alongside sub-400ms finality for low-latency, high-speed applications. Achieving that throughput would deliver execution speeds 50 times faster than any other mainnet chain, comparable to Web2-level transaction performance.

Advanced features including Autobahn consensus, a multi-proposer architecture, and the 5 gigagas throughput target are currently in development. Sei Labs has already achieved 5 gigagas of throughput in an internal devnet using Autobahn, a new consensus protocol designed for high throughput and low latency in globally distributed validator networks.

Bringing Bilinear's engineering resources in-house signals that Sei Labs is consolidating specialist talent rather than relying on external contributors as Giga moves closer to production. For the $SEI ecosystem, the acquisition adds depth on the data and systems side at a point when the protocol's technical roadmap is at its most complex.

Sources
Sei Labs publishes Sei Giga whitepaper, Sei Blog
Sei Labs releases Giga roadmap, Business Wire

NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation (“UWM” or the “Company”) (NYSE: UWMC).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether UWM and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until October 13, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired UWM securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.        

[Click here for information about joining the class action]

In December 2025, UWM and Two Harbors Investment Corp. (“Two Harbors”) (owner of RoundPoint Mortgage Servicing) signed an all-stock merger agreement valued at $1.3 billion to expand UWM's mortgage servicing rights (MSRs).  However, in March 2026, Two Harbors terminated the UWM agreement after CrossCountry Mortgage stepped in with a competing cash offer and agreed to pay UWM's termination fee. UWM aggressively countered by raising its proposals, but Two Harbors' board repeatedly rebuffed these advances, leading to a brief mandated negotiation waiver period in June 2026 that expired without a new deal.  On August 5, 2026, after the market closed, UWM reported second quarter fiscal year 2026 financial results, including a $603.2 million interest rate derivatives loss which contributed to a $451.9 million second-quarter net loss. Total equity also fell 43.6% year over year, reflecting the net loss and derivative-related charges.  Then, on August 6, 2026, at 10:30 AM EDT, the Company held an earnings call in connection with its second quarter 2026 financial results. During that call, Chief Executive Officer Mathew Ishbia (“Ishbia”) disclosed “We were over-hedged, if you think of it that way, protecting against the Two Harbors transaction.” Ishbia further stated “[w]e don't traditionally hedge our MSRs [Mortgage Servicing Rights]” but “when you're going through and acquiring a company like Two Harbors and a massive MSR book . . . it created a little more risk. So . . . we did put a hedge on to protect against that risk and then a lot of things happen[ed] . . . and then obviously, the Two Harbors transaction went away.  And so a confluence of events that created a hedge loss.” 

On this news, UWM’s stock price fell $0.64 per share, or 34.78%, to close at $1.20 per share on August 6, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

Key Takeaways MKL is partnering with Midwest to expand small-business workers' compensation coverage in California.Midwest's online quoting and established platform could help Markel reach smaller accounts more efficiently.MKL can use Midwest's data-driven approach to improve risk selection and pricing amid rising cost pressures. Markel Group (MKL - Free Report) is expanding its workers' compensation business in California through a collaboration with Midwest General Insurance Agency, a subsidiary of Acrisure.

The partnership will focus on small-business workers' compensation coverage. Midwest brings more than 20 years of experience in the California market and offers online quoting capabilities, which could help Markel access smaller accounts more efficiently.

The move could support Markel's insurance business by expanding its addressable market in one of the largest and most competitive workers' compensation markets in the United States. Midwest already has capabilities spanning marketing, underwriting, policy issuance, claims and loss control. This established platform could allow Markel to broaden its reach without having to develop an entirely new distribution infrastructure.

However, California's workers' compensation market is facing rising cost pressures. The state adopted an average advisory pure premium rate that is 6.6% higher than the 2025 level, effective Sept. 1, 2026.  This makes disciplined underwriting particularly important for Markel as it expands its business in the state.

Midwest's data-driven approach to account selection could benefit Markel. Better risk selection and appropriate pricing for rising medical and claims costs can help the insurer grow premiums while maintaining underwriting discipline.

The collaboration gives Markel an efficient avenue to expand its small-business workers' compensation portfolio in California and could support premium growth over the long term.

What About Its Peers?The Travelers Companies, Inc. (TRV - Free Report) has expanded its digital small-business quoting capabilities, making workers’ compensation available through its platform in more than 30 states. Its use of data and analytics can help improve risk selection and streamline policy issuance.

Berkshire Hathaway Inc. (BRK.B - Free Report) , through its GUARD business, has also been expanding its workers’ compensation business through partnerships. In 2025, GUARD partnered with London Underwriters to allow agencies to quote and bind its workers’ compensation policies through the LU One digital platform. GUARD also works with hundreds of payroll-service partners to distribute its workers’ compensation products.

MKL’s Price PerformanceShares of MKL have lost 5.3% in the past year against the industry’s growth of 8.8%.

Image Source: Zacks Investment Research

MKL’s UndervaluationThe stock is undervalued compared with its industry. Its forward price-to-book value of 1.19X is lower than the industry average of 2.70X. It carries a Value Score of B.

Image Source: Zacks Investment Research

Estimate Movement for MKLThe Zacks Consensus Estimate for Markel’s 2026 earnings per share (EPS) indicates a year-over-year increase of 13.5%.

The consensus estimate for revenues is pegged at $15.9 billion, implying a year-over-year improvement of 3.9%.

The consensus estimate for 2027 EPS and revenues indicates an increase of 9.9% and 1.2%, respectively, from the corresponding 2026 estimates.

The Zacks Consensus Estimate for 2026 and 2027 earnings have moved 0.7% and 1% south, respectively, over the last 30 days.

Image Source: Zacks Investment Research

MKL stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways Insulet's Q2 Omnipod revenues rose 23.8% at constant currency as global customer adoption expanded. Insulet raised 2026 international Omnipod constant-currency growth guidance to 30-32%. Competition, tariffs, supply constraints and manufacturing expansion could pressure margins. Insulet (PODD - Free Report) is well poised for growth in the upcoming quarters, owing to its strong momentum for the Omnipod 5 automated insulin delivery (“AID”) system for both Type 1 and Type 2 populations. The company is strongly executing against its long-term priorities to drive penetration, deepen competitive advantage, unlock new opportunities and scale profitably. However, macroeconomic pressures and intense competition could pose headwinds for Insulet’s operations.

In the past year, this Zacks Rank #3 (Hold) stock has lost 57.8% compared with the industry’s 27% decline. The S&P 500 composite grew 20% in the same time frame.

The developer, manufacturer and distributor of insulin delivery systems has a market capitalization of $16.21 billion. The company’s estimated long-term earnings growth rate of 22.2% is well ahead of the industry’s 12.5% rise. PODD’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 13.6%.

Let us delve deeper.

Upsides for InsuletOmnipod 5 Expanding Global Adoption: Omnipod 5 remains differentiated as a fully disposable, tubeless AID system and continues to expand its installed base across U.S. and international markets. In the second quarter of 2026, total Omnipod revenues rose 23.8% at constant currency, including U.S. growth of 20.1% and international growth of 32.9%. Global new customer starts increased sequentially and year over year, producing the company’s second-highest quarter to date. 

The global customer base increased 23% year over year. More than 95% of the U.S. customer base and over 70% of the international customer base were using Omnipod 5 in the second quarter. International adoption also broadened through the Spain launch, bringing Omnipod to 26 countries and Omnipod 5 to 20. Management raised 2026 international Omnipod constant-currency growth guidance to 30% to 32%, reflecting sustained first-half momentum and continued adoption across international markets. 

Progress With Strategic Actions: Insulet is extending sensor connectivity and advancing next-generation systems to deepen the Omnipod platform over time. In the second quarter of 2026, the company launched its latest U.S. Omnipod 5 algorithm update, including a 100 mg/dL target glucose option, and expanded compatibility with Abbott’s FreeStyle Libre 3 Plus. Insulet continues to target a 2027 launch for Omnipod 6 and is progressing enrollment in the EVOLVE pivotal study for its fully closed-loop Type 2 system, with a 510(k) submission still planned for 2027. 

Omnipod Discover is also gaining use, with more than 12,000 people with diabetes and over 1,600 health care professionals on the platform in the second quarter. These initiatives broaden the product roadmap and may support longer-term retention and access as the company scales beyond its current user base.

Image Source: Zacks Investment Research

What Ails PODD Stock?Competitive Pressure: Insulet competes against large, established diabetes device companies and newer entrants offering pumps, smart pens and other insulin delivery approaches. As AID adoption expands globally, management expects competition to increase, which can raise commercial spending requirements and heighten payer negotiations. If competitive intensity continues to rise, Insulet may need to sustain elevated commercial spending to support customer growth, which could limit operating leverage and margin expansion.

Economic Uncertainty and Supply Exposure: Insulet remains vulnerable to geopolitical, logistics and input-cost disruptions across its global manufacturing network. The company faces risks from potential tariff expansion, supply constraints and price fluctuations among sole-source and third-party suppliers. Insulet is also expanding manufacturing capacity, including a new Costa Rica facility, which adds execution risk as production scales. The longer-term risk is that higher input costs, trade changes or supply disruptions could absorb part of the productivity and scale benefits required to sustain annual margin expansion.

PODD Stock Estimate TrendThe Zacks Consensus Estimate for Insulet’s 2026 earnings per share has moved north 0.5% to $6.51 in the past 30 days.

The same for the company’s 2026 revenues is pegged at $3.28 billion, implying a 21.1% rise from the year-ago reported number.

Key PicksSome better-ranked stocks in the broader medical space are Globus Medical (GMED - Free Report) , Veracyte (VCYT - Free Report) and Illumina (ILMN - Free Report) .

Globus Medical has an earnings yield of 5.8% against the industry’s negative 1.7% yield. Its earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 27.9%. GMED’s shares have rallied 42.3% against the industry’s 6.3% decline over the past year.

GMED sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Veracyte, sporting a Zacks Rank #1 at present, has an earnings yield of 4.6% against the industry’s negative 1.7% yield. Shares of the company have risen 38% against the industry’s 6.3% decline. VCYT’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 41.8%. 

Illumina, presently carrying a Zacks Rank #2 (Buy), has an estimated long-term earnings growth rate of 13% compared with the industry’s 23% rise. Its earnings beat estimates in each of the trailing four quarters, the average surprise being 9.7%. ILMN’s shares have rallied 194.6% compared with the industry’s 24.6% growth over the past year.

Starknet just rolled out privacy protection for 45 ERC-20 assets through its new STRK20 framework, branded as Shieldnet. The system uses client-side zero-knowledge proofs to convert tokens into encrypted notes, making transaction details invisible to outside observers while still allowing selective disclosure for regulatory compliance.

How Shieldnet actually works The STRK20 framework operates on a note-based ZK system. When users interact with it, their assets are converted into encrypted notes that appear only as metadata on-chain. The sender, receiver, and transfer amounts are all hidden from public view.

This is fundamentally different from crypto mixers like the now-sanctioned Tornado Cash. Rather than pooling funds together to obscure their origins, Shieldnet enables selective lawful disclosure through encrypted viewing keys. Users can share these keys with regulators or auditors when required, revealing only the relevant transaction data while keeping everything else confidential.

The framework supports shielded transactions across DeFi applications, not just simple transfers. Protocols like AVNU and Ekubo are already integrated, meaning users can swap and provide liquidity with privacy features baked into the experience. Supported wallets include Xverse and Ready X.

The rollout timeline The STRK20 framework was first announced in March 2026, followed by a protocol upgrade tagged SHINOBI/v0.14.2 on April 21, 2026, which laid the technical groundwork. The first asset to go live under the framework was strkBTC, launched on May 12, 2026. USDC followed in June, and the full implementation covering 45 assets was completed by June 9, 2026.

Early engagement numbers look respectable for a brand-new privacy system. The privacy pool has processed more than 14,000 deposit transactions, with total value locked reaching approximately $350K shortly after launch.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Lennar (NYSE:LEN – Get Free Report) is expected to release its Q3 2026 results after the market closes on Wednesday, September 16th. Analysts expect Lennar to post earnings of $1.29 per share and revenue of $8.3069 billion for the quarter. Interested persons may visit the the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Thursday, September 17, 2026 at 11:00 AM ET.

Lennar (NYSE:LEN – Get Free Report) last released its quarterly earnings results on Thursday, June 11th. The construction company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.07. Lennar had a net margin of 4.93% and a return on equity of 7.08%. The company had revenue of $7.94 billion for the quarter, compared to analyst estimates of $8.08 billion. During the same quarter last year, the firm posted $1.81 earnings per share. The company’s quarterly revenue was down 5.2% compared to the same quarter last year. On average, analysts expect Lennar to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Lennar Price Performance Shares of Lennar stock opened at $80.56 on Wednesday. The company has a current ratio of 4.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.19. The firm has a fifty day simple moving average of $85.29 and a 200-day simple moving average of $90.27. The stock has a market capitalization of $19.41 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 2.78 and a beta of 1.39. Lennar has a 1-year low of $79.82 and a 1-year high of $141.84.

Lennar Announces Dividend The company also recently announced a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Friday, July 10th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.5%. The ex-dividend date was Friday, July 10th. Lennar’s dividend payout ratio (DPR) is 31.30%. Wall Street Analysts Forecast Growth A number of equities research analysts have issued reports on the stock. UBS Group decreased their price target on shares of Lennar from $107.00 to $94.00 and set a “neutral” rating for the company in a report on Tuesday, June 16th. Evercore lifted their price objective on Lennar from $82.00 to $87.00 and gave the stock an “underperform” rating in a research note on Monday, June 15th. Argus set a $108.00 price objective on Lennar in a research report on Thursday, July 9th. Royal Bank Of Canada lowered their target price on Lennar from $88.00 to $85.00 and set an “underperform” rating on the stock in a report on Monday, June 15th. Finally, JPMorgan Chase & Co. dropped their price target on Lennar from $80.00 to $77.00 and set an “underweight” rating on the stock in a research report on Tuesday, June 16th. One equities research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and ten have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $92.13.

Get Our Latest Report on LEN

Institutional Investors Weigh In On Lennar Several hedge funds have recently made changes to their positions in LEN. DV Equities LLC bought a new position in Lennar during the fourth quarter valued at about $31,000. Quarry LP acquired a new stake in shares of Lennar during the 4th quarter worth approximately $41,000. IFC & Insurance Marketing Inc. acquired a new stake in shares of Lennar during the 4th quarter worth approximately $45,000. Cary Street Partners Financial LLC bought a new stake in shares of Lennar during the second quarter valued at approximately $47,000. Finally, EFG International AG acquired a new position in shares of Lennar in the fourth quarter valued at $62,000. Institutional investors own 81.10% of the company’s stock.

Lennar Company Profile (Get Free Report)

Lennar Corporation (NYSE: LEN) is a U.S.-based homebuilder and real estate company that designs, constructs and sells residential housing. The company offers a range of product types including single-family detached homes, townhomes and condominiums, serving buyers from entry-level and first-time purchasers to move-up, active-adult and luxury segments. Lennar also develops master-planned communities and manages land acquisition and entitlement activities that support its homebuilding operations.

In addition to home construction and sales, Lennar provides a suite of ancillary services intended to streamline the purchase process and capture additional value.

Featured Articles Five stocks we like better than Lennar Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For

Receive News & Ratings for Lennar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lennar and related companies with MarketBeat.com's FREE daily email newsletter.

Public Employees Retirement System of Ohio purchased a new stake in Teleflex Incorporated (NYSE:TFX – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 12,584 shares of the medical technology company’s stock, valued at approximately $1,595,000.

Several other institutional investors have also recently made changes to their positions in TFX. Corient Private Wealth LP bought a new stake in Teleflex in the 2nd quarter valued at about $3,006,000. Bank of America Corp DE bought a new position in Teleflex in the second quarter worth approximately $61,156,000. Boone Capital Management LLC bought a new position in Teleflex in the second quarter worth approximately $49,105,000. Freestone Grove Partners LP acquired a new stake in Teleflex in the second quarter valued at approximately $9,070,000. Finally, Man Group plc acquired a new stake in Teleflex in the second quarter valued at approximately $1,686,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets Several research firms have recently commented on TFX. Mizuho boosted their price objective on Teleflex from $140.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, July 15th. Truist Financial increased their target price on Teleflex from $143.00 to $150.00 and gave the stock a “hold” rating in a report on Monday, August 10th. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research report on Sunday, August 9th. UBS Group upped their price objective on shares of Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. Finally, BMO Capital Markets began coverage on Teleflex in a report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Teleflex currently has a consensus rating of “Hold” and an average price target of $152.90.

Read Our Latest Stock Report on TFX Teleflex Stock Performance NYSE TFX opened at $138.21 on Tuesday. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $145.00. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. The firm has a market cap of $5.86 billion, a price-to-earnings ratio of -5.93, a PEG ratio of 0.92 and a beta of 0.82. The company has a fifty day moving average price of $135.50 and a 200-day moving average price of $127.52.

Teleflex (NYSE:TFX – Get Free Report) last announced its earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. During the same quarter in the prior year, the company posted $3.73 earnings per share. The firm’s revenue for the quarter was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.

Teleflex Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.84%.

Teleflex Company Profile (Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Further Reading Five stocks we like better than Teleflex 3 Under-the-Radar Defense Stocks With Record Backlogs This Korea ETF Has Soared, But the Rally May Not Be Over Why Guidewire’s Post-Earnings Plunge May Not Last Ride-Share Reckoning: Tesla Drives Into Uber’s Lane

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Shares of Dyne Therapeutics (DYN.O) and Sarepta (SRPT.O) slumped on Tuesday after Novartis' (NOVN.S) treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat rare ‌disease.

Dyne's stock led declines among companies developing a treatment for myotonic dystrophy type 1, tumbling nearly 18%. Shares of Sarepta and PepGen (PEPG.O) fell more than 9% and ​5%, respectively. Novartis' shares closed 10.9% lower on the Swiss exchange ​on Tuesday.

The genetic disorder, which causes progressive muscle weakness and delayed muscle ⁠relaxation known as myotonia, has no approved treatments. Drug development for it ​has been challenging, with several companies, including Biogen (BIIB.O), abandoning or shelving ​their programs over the past decade.

"This definitely increases the risk for the space, and it's a disappointment, a $12 billion disappointment," Oppenheimer analyst Kostas Biliouris said.

Novartis acquired the ​drug through its $12-billion acquisition of Avidity.

The failure was particularly concerning for Dyne as its ​trial, like Novartis', uses video hand opening time - how quickly a patient's hand relaxes after ‌squeezing - as ⁠a key trial goal for its candidate, DYNE-101.

"The (Novartis) failure makes Dyne's own trial much more risky," Cantor Fitzgerald analyst Eric Schmidt said.

Novartis said late-stage trial data showed its drug, del-desiran, failed to show a statistically significant improvement over placebo ​on video hand ​opening time.

The Swiss company ⁠did not disclose numerical results, saying that it is evaluating the full dataset and will engage with health authorities ​to determine the most appropriate development path for ​the drug.

"The ⁠big question is whether it's an endpoint miss or... whether mechanism has completely failed or not," said H.C. Wainwright analyst Ananda Ghosh.

Dyne plans to present ⁠additional ​one-year data at conferences this month.

Sarepta is ​evaluating an investigational small interfering RNA therapy called SRP-1003 in early stage trial for type ​1 myotonic dystrophy.

Key Takeaways POST's premium cereal portfolio is gaining market share despite continued category volume declines.Assortment changes are improving promotional efficiency and accounted for half the gap versus the category.POST expects cereal volumes to remain pressured as the category expects an approximately 2.5% decline in 2027. Post Holdings, Inc. (POST - Free Report) continues to navigate pressure in the cereal category, where volume trends remain soft amid category declines and distribution challenges in parts of its value cereal portfolio. At the same time, management is seeing encouraging signs in its premium cereal offerings, which are gaining market share, while broader category trends have been improving gradually.

The company’s premium portfolio is gaining market share, while management expects cereal volume performance to move closer to the category next year. Management tied part of the current gap with the category to assortment changes designed to improve promotional performance and efficiency. The assortment adjustments accounted for 1 percentage point of the gap versus the category, representing 50% of the gap. The remaining difference is tied to distribution losses in the Malt-O-Meal brand, particularly among lower-velocity SKUs, while the rest of the portfolio is performing well.

Despite continued pressure in the cereal category, Post Holdings highlighted that the category has been improving gradually quarter after quarter and is moving closer to its view of the category’s long-term sustainable trend of approximately negative 1% to negative 2%. The category has not yet reached that level, but management said that it is gradually getting closer. In addition, cereal could benefit from affordability trends, given that it remains one of the cheapest breakfast categories. It also provides a low-cost way to deliver the right nutrients in a breakfast, which management believes could make cereal a longer-term opportunity.

Looking ahead, management expects cereal to remain under volume pressure, with an initial assumption of approximately 2.5% cereal category decline in fiscal 2027, while noting that the exact outcome remains uncertain. However, management expects POST’s cereal volumes to move closer to category performance next year, while cereal’s affordability could provide a longer-term category opportunity.

The Zacks Rundown for POSTThe company’s shares have lost 7.5% in the past three months against the industry’s 6% growth.

Image Source: Zacks Investment Research

From a valuation standpoint, POST trades at a forward price-to-earnings ratio of 12.40, lower than the industry’s average of 14.74. POST currently carries a Zacks Rank #3 (Hold).

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for POST’s current fiscal year earnings implies a year-over-year increase of 4.6%, and the same for next fiscal year earnings implies a decline of 10.3%.

Image Source: Zacks Investment Research

Stocks to ConsiderSome better-ranked stocks have been discussed below:

The Chef’s Warehouse, Inc. (CHEF - Free Report) distributes specialty food and center-of-the-plate products in the United States, the Middle East, and Canada. CHEF currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for CHEF’s current fiscal-year sales and earnings indicates growth of 10.6% and 33.7%, respectively, from the year-ago reported figures. CHEF delivered a trailing four-quarter earnings surprise of 30.4%, on average.

Darling Ingredients Inc. (DAR - Free Report) develops, produces, and sells sustainable natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America, and internationally. DAR currently carries a Zacks Rank #2 (Buy).

The Zacks Consensus Estimate for DAR’s current fiscal-year sales and earnings implies growth of 11.5% and 926.5%, respectively, from the year-ago actuals. DAR delivered a trailing four-quarter negative earnings surprise of 38.9%, on average.

Utz Brands, Inc. (UTZ - Free Report) , together with its subsidiaries, markets, sells and distributes fresh, frozen, and dry food and non-food products to foodservice customers in the United States. UTZ currently carries a Zacks Rank #2.

The Zacks Consensus Estimate for UTZ’s current fiscal-year sales implies growth of 3.7%, and the same for earnings implies a decline of 2.4% from the year-ago actuals. UTZ delivered a trailing four-quarter earnings surprise of 1.8%, on average.

Franklin Templeton digital asset veteran takes helm at StablecoinXLatest NewsPublishedSep 8, 2026

Former Franklin Templeton digital asset executive Christopher Jensen will lead StablecoinX, the largest corporate holder of Ethena’s ENA token.

StablecoinX appointed former Franklin Templeton digital asset executive Christopher Jensen as CEO, putting him in charge of the largest corporate holder of Ethena’s ENA token.

Jensen succeeds Ted Chen, who led StablecoinX through its public listing in June and will remain chairman of the company’s board.

StablecoinX, which trades on Nasdaq under the ticker USDE, is a publicly listed company focused on the Ethena ecosystem. Ethena issues USDe, a synthetic dollar that ranks as the fifth-largest stablecoin with nearly $4.4 billion in circulation, according to DefiLlama data. ENA, Ethena’s governance token, gives holders voting rights over changes to the protocol.

StablecoinX holds about 3.03 billion ENA tokens, roughly 20% of the token’s total supply, which the company says makes it ENA’s largest corporate holder.

Before joining StablecoinX, Jensen was a portfolio manager and director of digital asset research at Franklin Templeton, where he helped build the firm’s digital asset group after its launch in 2018. The asset manager’s blockchain venture fund participated in Ethena’s seed round, giving Jensen exposure to the protocol from its early stages.

The appointment comes about a week after Ethena launched Ethena Pay, a self-custodial app that lets users spend, save and transfer its USDe synthetic dollar.

The ENA token remains down about 20% year to date but has rebounded sharply in recent weeks, gaining more than 80% over the past month to trade around $0.16, according to CoinGecko.

ENA token price over the past month. Source: CoinGecko

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently.

Supermicro's gross margin just shattered expectations, sending shares surging, but management quietly buried a number in the earnings call that changes everything investors think they just bought.

Super Micro Computer (NASDAQ:SMCI | SMCI Price Prediction) closed most recently at $39.59, up 25.8% over one month and 27.9% year to date, yet still 1.1% lower over the trailing year. The rally traces to a fiscal fourth-quarter 2026 report in which non-GAAP gross margin blew past guidance. Did investors buy a structural margin reset or a one-quarter timing artifact? As it turns out, management answered that question on the earnings call.

What the Market Thinks It Bought The bull case is genuine. Non-GAAP EPS came in at $1.70 against a $0.9575 estimate, revenue grew 93.16% year over year, and CEO Charles Liang cited “more than $60 billion in new orders, and booked record backlog entering fiscal 2027.” Full fiscal 2027 revenue guidance is $65.0 billion to $72.0 billion. Some of last week’s strength was sector-driven; TradingView, on September 4, 2026, headlined the story “Supermicro’s Revenue Boom Just Ran Into a Profit Test.”

What the Margin Number Actually Was Reported non-GAAP gross margin was 17.6% versus guidance of 8.2% to 8.4%, a 750 basis point sequential jump. CFO David Weigand said favorable mix “contributed approximately 75% of the gross margin improvement,” with the remainder attributable to lower tariff costs and lower inventory reserves, which he called a “non-recurring event.” The mix itself was inflated by “the deferral of several contracts from Q4 fiscal year 26 to Q1 fiscal year 27.” Lower-margin revenue slipping out lifts the percentage without improving the business. Liang said, “This margin expansion mainly came from our strategy focused on balancing customer mix and product mix while having a one-time positive contribution for the quarter.” Revenue landed near the low end of the $11 billion to $12.5 billion range on customer readiness delays. Miss on top line, beat on margin, same cause.

Guidance Nobody Talked About Management guided current-quarter non-GAAP gross margin to 10.4% to 10.8%, well below the reported 17.6%. A quiet period begins at the close of business on Friday, September 11, 2026, so this number stands.

Parts of the Bull Case That Survive Customer diversification is genuine. David Weigand noted nine customers with revenues greater than $1 billion each in fiscal year 2026, versus four in fiscal year 2025. Full-year revenue reached $39.06 billion (+77.8% year over year). (That kind of concentration in AI server buildouts is why we keep pointing readers to the power, cooling, and networking suppliers behind the data centers in a free report.)

Offsetting this is that fiscal 2026 operating cash flow was negative $6.81 billion, closing inventory rose to $12.9 billion, and the cash conversion cycle (days between paying suppliers and collecting from customers) lengthened materially. A company can grow revenue while consuming cash when it prepays inventory faster than customers pay invoices.

Dilution Nobody Prices Supermicro raised $5.6 billion in public equity, including $4.2 billion in mandatory convertible preferred (shares that automatically convert to common). The guided non-GAAP diluted share count is 761 million. David Weigand said EPS is now computed using the two-class method, allocating a portion of net income to participating convertible preferred shares.

What Has to Go Right Gross margin must hold against the new 10.4% to 10.8% guidance. The deferred contracts must land without dragging margin lower when they do. The $65.0 billion to $72.0 billion revenue range must survive a quarter of contact, and growth must start generating operating cash. This thesis will be disproved by any quarter in which revenue grows and gross margin lands at or below the full prior-year level, or any walk-back of the forward revenue range.

Committed View The market bought a margin figure that management, in its own words and its own next-quarter guide, has already told investors will not repeat. Though the growth story is intact and the order book is a genuine asset, the profitability step-up appears transitory.

Contact [email protected] for any questions or corrections.

The AI infrastructure space features many companies that are growing at a dramatic clip. However, growth alone is often not enough to satisfy many investors. Some of the fastest-growing names in this space also have among the most investors betting against them.

Three AI companies stick out, with investors selling short a huge percentage of their public floats, indicating significant pessimism among many market participants. However, these companies also have avenues to potentially prove short sellers wrong as they look to improve profitability metrics.

Get Super Micro Computer alerts:

Super Micro Computer: Data Center Building Blocks Solution Aims to Improve Margin ProfileSuper Micro Computer Today

SMCI

Super Micro Computer

$40.26 +0.67 (+1.69%)

As of 09/8/2026 04:00 PM Eastern

$19.48▼

$58.7812.58

$42.13

First up is AI server giant Super Micro Computer NASDAQ: SMCI. Investors have sold approximately 18% of its floated shares short, making Super Micro one of the most-shorted stocks in the market.

There are multiple reasons that investors may be betting on this name to fall. First off, shares are up over 30% in one month, creating more downside potential that shorts can profit from. Additionally, the company’s growth is rapid, but its profitability profile is a real concern. Analysts expect sales to grow by nearly 200% year-over-year (YOY) next quarter to almost $15 billion, but forecast a gross margin below 11%. This very low margin makes it difficult for the company to convert much of its sales into earnings.

However, one key offering that could potentially help Super Micro improve its profitability over time is its data center building blocks solution (DCBBS). Super Micro describes DCBBS as a turnkey ecosystem that allows customers to build AI data centers in quarters rather than years. This comes as it integrates a wide variety of key data center components, from processors to networking to cooling systems and software.

With this, it will be important to monitor mentions of DCBBS’s revenue contribution and DCBBS deal signings. Notably, the company says that the platform will soon contribute significant net income, another factor to watch.

CoreWeave Adds Record Active Power, But Profits Are Under PressureCoreWeave Today

$99.83 +10.47 (+11.72%)

As of 09/8/2026 04:00 PM Eastern

$60.55▼

$153.20$141.90

CoreWeave NASDAQ: CRWV also finds itself among the list of AI stocks with very high short interest. Investors have sold nearly 17% of the company’s floated shares short. Not unlike Super Micro, the company is posting blistering growth but has profitability issues.

Sales increased by 112.5% YOY last quarter to $2.575 billion, but earnings moved in the opposite direction. The company’s loss per share greatly increased to -$1.14, and free cash flow fell much further into negative territory, coming in at -$5.74 billion. Additionally, CoreWeave’s long-term debt rose by more than 270% YOY to $27.56 billion.

For CoreWeave, it is critical that the company closes the gap between its revenue and cash flow and its capital expenditures. One factor that can help with this is bringing online its in-progress data centers as quickly as possible. This can maximize the revenue CoreWeave generates from each facility over time to offset costs.

Notably, the company added 500 megawatts of actively powered data centers last quarter, more than any quarter in its history. It now has 1.5 gigawatts of actively powered data centers, with the company targeting eight gigawatts by 2030. Investors should monitor CoreWeave’s active power additions each quarter and its ability to increase its overall active power consistently over time.

Expenditures Set to Balloon as IREN Eyes Huge Jump in Operating Run-RateIREN Today

$46.93 +2.25 (+5.04%)

As of 09/8/2026 04:00 PM Eastern

$27.05▼

$76.87$81.57

IREN NASDAQ: IREN operates a somewhat similar business model to CoreWeave, falling in the neocloud category. However, the company has its roots in bitcoin mining and has since converted much of this infrastructure to serve the AI market. There is clearly a large cohort of investors who are skeptical of the company’s future, with nearly 28% of its floated shares sold short.

Notably, IREN has a $9.7 billion contract with Microsoft NASDAQ: MSFT. However, turning that deal into actual sales comes with execution risk and massive costs. To support this and other deployments, IREN expects to spend $25-30 billion on capital expenditures between now and Q2 2027. These figures tower over the company’s small revenue base today.

Sales came in at just $137 million last quarter, and its operating annualized run rate (ARR) revenue is $1 billion. However, the company expects to make significant progress on this front soon, targeting an increase in operating ARR to $4 billion next quarter. This comes as IREN plans to bring a large amount of data center capacity online. This would greatly increase the company’s revenue base, improving profits over time, after it posted a net loss of $684 million last quarter.

Whether IREN actually delivers on this figure will be among the most critical aspects to watch in its next earnings report. From there, the company will need to continue making strong progress in adding more capacity to maximize its data center revenue.

Short Sellers Are Targeting Growth, But Execution Will Decide the TradeIREN’s percentage of floated shares sold short is by far the highest in this group, indicating particularly high bearish sentiment among short sellers. Interestingly, Wall Street analysts are showing the most optimism about IREN among the group. The MarketBeat consensus price target of $81.57 implies more than 80% upside.

Still, the broader takeaway is not just about IREN. Super Micro, CoreWeave, and IREN all show the same tension running through the AI infrastructure trade: demand is enormous, but investors want clearer evidence of margin expansion, cash flow improvement and disciplined capital spending.

Short sellers may be focused on the risks, but these companies still have ways to challenge the bear case. For Super Micro, that means proving DCBBS can support profitability. For CoreWeave, it means turning capacity additions into better cash flow. For IREN, it means showing that contracted AI revenue can scale fast enough to justify the spending required to support it.

Should You Invest $1,000 in Super Micro Computer Right Now?Before you consider Super Micro Computer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Super Micro Computer wasn't on the list.

While Super Micro Computer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Key Takeaways Bloom Energy gained 20% as AI data-center demand and adoption of distributed energy solutions increased. BE's Brookfield partnership expanded planned AI power investment from $5 billion to $25 billion.BE raised 2026 revenue guidance to $3.9-$4.2 billion, while its forward P/S remains above the industry. Shares of Bloom Energy Corporation (BE - Free Report) have gained 20% in the past month against the Zacks Alternative Energy - Other industry’s decline of 0.1%. The company has also outperformed the Zacks Oil & Energy sector’s return of 3.6% and the S&P 500’s decline of 0.8% in the same time frame.

Bloom Energy is benefiting from rising demand for clean energy from AI-driven data centers, along with growing adoption of distributed energy solutions as customers seek to overcome transmission and distribution constraints.

The company will be added to the S&P 500 on Sept. 21, 2026. Inclusion in the benchmark index could further support the stock by strengthening investor confidence, increasing trading activity and potentially driving additional share-price appreciation.

Price Performance (One Month)
Image Source: Zacks Investment Research

Another industry player, Talen Energy Corporation (TLN - Free Report) , operates a fleet of power generation assets that deliver reliable, dispatchable electricity to meet the around-the-clock needs of commercial, industrial and residential customers. Talen Energy has lost 7.6% in the past month, underperforming its industry, the sector and the S&P 500.

Should investors consider adding BE to their portfolios simply because of its recent price rally? A closer look at the company’s key fundamentals and growth drivers can help determine whether the stock presents an attractive investment opportunity now.

What’s Powering Bloom Energy’s Share Price Gains?Bloom Energy is expanding its onsite power platform to address electricity shortages, long deployment timelines and rising energy costs. The company stands to benefit from several structural trends, including rapid AI infrastructure growth, constrained grid capacity, increasing demand for reliable and affordable power, and government initiatives supporting energy independence and domestic manufacturing.

Its Energy Server platform delivers scalable onsite electricity by connecting directly to customers’ electrical systems, reducing reliance on traditional transmission infrastructure. Based on Bloom Energy’s proprietary solid oxide technology, the system generates electricity through an efficient electrochemical process, providing dependable and cleaner power to commercial and utility customers. Adoption could continue to rise among AI data centers, cryptocurrency miners, advanced manufacturers and other power-intensive industries.

Bloom Energy and Brookfield also expanded their strategic partnership, increasing planned investment in AI-related power infrastructure from $5 billion to $25 billion. This fivefold increase underscores the sharp rise in electricity demand stemming from the global expansion of hyperscale AI data centers.

The financial benefits of this demand are already becoming visible. Revenues more than doubled year over year to $1.8 billion in the first half of 2026, with AI data centers emerging as an important growth driver. Reflecting this momentum, Bloom Energy raised its 2026 revenue guidance to $3.9-$4.2 billion and expects a non-GAAP gross margin of about 34%, indicating that strong top-line growth is being accompanied by healthy profitability.

BE’s EPS Estimates Moving UpThe Zacks Consensus Estimate for BE’s third-quarter and fourth-quarter 2026 earnings per share (EPS) witnessed northbound movement in the last 60 days. The same holds true for full-year 2026 and 2027 EPS estimates.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Talen Energy’s 2026 earnings per share declined 5.2% and 2027 estimates increased 5.92% in the past 60 days.

BE’s Expensive ValuationBloom Energy is currently trading at a premium valuation. Its forward 12-month price-to-sales (P/S) ratio of 12.94X is higher than the industry’s 4.89X.

Image Source: Zacks Investment Research

Another company, Plug Power Inc. (PLUG - Free Report) , is also working to produce clean energy for its customers. Plug Power is currently trading at a P/S F12M of 3.26X, a discount to the industry.

BE’s Earnings SurpriseBloom Energy is delivering strong earnings performance courtesy of rising demand for its services. The company’s earnings surpassed estimates in the past four quarters.

Image Source: Zacks Investment Research

Plug Power’s earnings also surpassed estimates in each of the past four quarters, resulting in an average surprise of 17.83%.

BE Stock Returns Better Than Its IndustryThe return on equity (“ROE”) measures how well a company is utilizing its shareholders’ funds to generate profits. ROE compares net income with shareholders' equity.

ROE of Bloom Energy was 35.45% compared with the industry average of 7.14%.

Image Source: Zacks Investment Research

Wrapping UpBloom Energy continues to deliver steady performance, supported by growing demand for clean energy and its ability to provide on-site power solutions tailored to customer needs. Demand is expected to strengthen further as the adoption of flexible, distributed generation expands.

Bloom Energy’s strong price performance, rising earnings estimates and returns better than the industry average enhance its investment appeal.

Thus, despite the premium valuation at current levels, we believe this Zacks Rank #1 (Strong Buy) stock remains an attractive investment and recommend adding it to investors’ portfolios.

You can see the complete list of today’s Zacks #1 Rank stocks here.

Nancy Pelosi's husband quietly built a multimillion-dollar stake in a fuel-cell company weeks before a major index announcement sent its stock soaring. Whether that timing reflects brilliant research or something more raises uncomfortable questions about who really benefits from congressional…

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Former House Speaker Nancy Pelosi has done it again. An SEC filing on August 21, 2026 revealed that her spouse purchased a large position in Bloom Energy (NYSE:BE) in late July. Six weeks later, on September 4, 2026, S&P Dow Jones Indices announced Bloom Energy would join the S&P 500. The stock jumped more than 7% on Friday and is up 8% in morning trading today.

Bloom Energy shares are now up 214% year-to-date and 411% over the past year, trading around $274.07. Pelosi’s timing, once again, looks uncanny.

Breaking Down the $3 Million (or $12 Million) Bet According to the House Clerk periodic transaction report, Pelosi’s spouse executed four Bloom Energy purchases across two days:

On July 24, 2026: one common stock lot in the $1,000,001 to $5,000,000 band and one options lot in the same $1,000,001 to $5,000,000 band. On July 28, 2026: a second stock lot in the $500,001 to $1,000,000 band and a matching options lot in the $500,001 to $1,000,000 band. Because House disclosures report ranges rather than exact figures, the $3 million headline number reflects the low end. The upper bound of the range reaches roughly $12 million. The July 28 purchases landed the same evening Bloom reported Q2 earnings, when shares were trading around $186.58.

Why Bloom Energy Became the AI-Power Trade Bloom Energy has repositioned from a fuel-cell company into a critical supplier of onsite power to hyperscale AI data centers. Q2 FY2026 results filed with the SEC showed revenue of $1.07 billion, up 165.5% year over year, with product revenue of $935.41 million surging 215%. Non-GAAP EPS came in at $0.78 versus a $0.41 estimate, the company’s fourth consecutive beat.

CEO KR Sridhar told investors: “Today, all the major US hyperscalers and over a dozen US neoclouds, AI labs, and colocation data center operators have validated and approved our power solutions for their AI factories. Bloom is now a standard for AI onsite power.” Management raised full-year 2026 guidance to $3.90 billion to $4.20 billion in revenue, roughly doubling 2025.

Same Thesis, Different Tickers Pelosi’s bet fits inside the broader AI-infrastructure trade playing out across silicon and power. Broadcom (NASDAQ:AVGO | AVGO Price Prediction) reported Q3 AI semiconductor revenue of $16.70 billion, up 221% year over year, and guided Q4 AI chip revenue to $21.7 billion. AMD (NASDAQ:AMD) posted Data Center revenue of $6.72 billion, up 107%, and inked a partnership with Anthropic covering up to 2 GW of MI450 Series GPUs.

Every one of those GPUs needs electricity. That is why American Electric Power (NYSE:AEP) is seeing commercial load up 14.9% in its Vertically Integrated segment and has contracted load growth of 69 GW through 2030. Bloom’s pitch is that hyperscalers cannot wait on grid interconnection queues, so they buy Energy Servers directly (we profiled seven of the power, cooling, and networking suppliers riding this same buildout, none of them chipmakers, in a free report here: 7 Stocks Powering the AI Boom).

Insider Information or Just Reading the Room? Pelosi’s trading record in Congress has consistently outpaced the S&P 500 and even Warren Buffett over comparable stretches, fueling suspicion that lawmakers with committee-level oversight enjoy an informational edge. Repeated bills to ban congressional stock trading, including the PELOSI Act and various ETHICS proposals, have stalled.

Investors should also note the mixed insider tape at Bloom itself. Directors and officers including Jeffrey Immelt sold 30,000 shares on August 17 at $238.91, while John Chambers disposed of 15,000 shares on August 13 at $250.00. Meanwhile, several securities class action deadlines loom, with a September 28, 2026 lead plaintiff deadline flagged across multiple law firm notices.

Bloom Energy’s official S&P 500 debut and Q3 earnings report will be the next catalysts to watch. Pelosi, at least on paper, is already sitting on a substantial paper gain.

Contact [email protected] for any questions or corrections.

NEWARK, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced its acquisition of CastleHill Managed Risk Solutions, a leading provider of Governance, Risk and Compliance (GRC), Third-Party Risk Management (TPRM), and AI governance solutions. The acquisition expands Concentrix’ ability to help organizations design, govern, and operate risk and compliance programs across the enterprise from a single partner.

CastleHill’s differentiated GRC-as-a-Service model brings together people, process, and technology to make governance and risk programs work in the messiness of real-world operations. Concentrix already helps organizations manage Financial Crime Operations, Cybersecurity Solutions, regulatory compliance, and other complex risk operations. CastleHill deepens and expands these capabilities.

Organizations are facing growing pressure from regulatory, cyber, third-party, data and compliance risks, with AI adding a new layer of complexity as it scales across the enterprise. CastleHill helps clients identify, govern, and manage these risks while building more resilient operations. The company brings a diverse portfolio of leading Banking, Financial Services, Manufacturing, and other regulated clients that complement Concentrix’ existing relationships. These capabilities are further strengthened by deep operational expertise and strategic partnerships with leading technology providers, including Archer, ProcessUnity, and OneTrust.

“Our clients recognize that AI-related risk across their enterprises is accelerating, and they need a partner with the deep domain expertise to design, implement, and operate these programs at scale,” said Chris Caldwell, President and CEO of Concentrix. “That’s exactly where we’re investing. Risk and Compliance is one of our fastest-growing specialized business lines, and CastleHill gives us even greater depth and scale to help clients navigate this rapidly evolving risk landscape.”

"Organizations need practical ways to manage risk while continuing to innovate,” said Tim Carbery and Michael Duggan, Co-Founders of CastleHill. "For years, we've helped clients navigate regulatory complexity, build and operationalize sustainable risk and compliance programs, and maximize the value of their GRC investments. Joining Concentrix combines that expertise with global scale, expanded capabilities, and operational excellence, helping our clients unlock even greater strategic value. We are excited about the opportunities ahead for our clients, our incredible team, and the business."

The acquisition deepens Concentrix' investment in Banking and Financial Services, bringing additional domain expertise, client relationships and expanding its ability to help clients manage the intersection of regulation, operational resilience, cybersecurity, AI, and risk. Together, Concentrix and CastleHill will help organizations simplify complexity and build more resilient, trusted businesses for this new reality. 

Terms of the transaction were not disclosed.

For more information, please visit https://www.concentrix.com/services-solutions/risk-compliance/

About Concentrix: Powering a World That Works
Concentrix (NASDAQ: CNXC), is the Fortune 500® technology and services company, helping the world's best brands create intelligent operations that perform in the real world. We design, build, and run integrated human and AI solutions, harnessing the insight from billions of real-world interactions to help 2000+ of the world’s most complex organizations solve their toughest business challenges. Backed by 20+ years of operational experience and battle tested AI, we’re the intelligent transformation partner that helps clients across every major industry move from ambition to measurable, scalable performance. Virtually everywhere. To learn more, visit concentrix.com.

Media Contact:
Marketing & Communications
Concentrix Corporation
[email protected]

From Fortune. ©2026 Fortune Media (USA) Corporation. All rights reserved. Used under license. Fortune and Fortune 500 are registered trademarks of Fortune Media (USA) Corporation and are used under license. Fortune and Fortune Media (USA) Corporation are not affiliated with, and do not endorse products or services of, Concentrix.

Safe Harbor Statement
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements regarding the company’s capabilities and positioning to deliver business outcomes and solve challenges for its clients, and statements that include words such as believe, expect, may, will, provide, could and should and other similar expressions. These forward-looking statements are inherently uncertain and involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, risks related to the company’s ability to successfully execute its strategy, competitive conditions in the company’s industry, and other factors contained in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2025 filed with the Securities and Exchange Commission and subsequent SEC filings. We do not undertake a duty to update forward-looking statements, which speak only as of the date on which they are made.

Copyright 2026 Concentrix Corporation and its subsidiaries. All rights reserved. Concentrix, the Concentrix logo, and all other Concentrix company, product and services names and slogans are trademarks or registered trademarks of Concentrix Corporation and its subsidiaries.

The EUR/JPY cross trades in negative territory near 178.50 during the early European trading hours on Wednesday. The Japanese Yen (JPY) edges higher against the Euro (EUR) as a slew of hawkish comments from the Bank of Japan (BoJ) policymakers have cemented views that the BoJ will raise interest rates this month.  

BoJ board member Hajime Takata said last week that the central bank could take a more aggressive approach than expected. Takata further stated that a 25-basis-point hike “is not necessarily set in stone,” and that generally speaking, back-to-back rate hikes would be a possibility, too.

The BoJ is set to raise its policy rate to 1.25% from the current 1.0% at its September policy meeting, signaling an acceleration in the pace of rate hikes. This would raise the interest rate to its highest level in about 31 years and follow a rate hike in June. 

Yen funding role questioned as rising JGB yields unsettle cross-border flowsStrategists at Rabobank argue that the “clear problem relates to the use of the JPY as a funding currency,” with markets now asking “whether there is room for the recent rapid unwind of JPY shorts to accelerate nearterm.” They add that an “appreciating JPY would bring fresh uncertainly over whether domestic Japanese investors would have less incentive to look for opportunity abroad,” a debate that has been sharpened by the rise in JGB yields, which has “already made this a topical theme.” Rabobank also notes that “the market has suspected that the US Treasury has been worried about large Japanese insurers potentially selling US government debt for JGBs for some time,” underscoring how shifts in Japan’s rate environment could reverberate through global fixed income positioning.

Technical Analysis: EUR/JPY keeps a bearish vibe amid oversold RSIIn the daily chart, EUR/JPY extends its corrective slide and holding decisively below key moving averages, which keeps the near-term bias firmly bearish. Price is lodged beneath the 20-day simple moving average (the middle Bollinger band) and the 100-day simple moving average, underscoring a market that remains capped by medium-term trend resistance. The Relative Strength Index (14) has dropped to around 22, deep in oversold territory, hinting that while downside pressure persists, the selloff could be at risk of fatigue if sellers fail to press decisively lower.

On the topside, initial resistance is seen at the lower Bollinger band near 179.00, with a recovery above this barrier needed to ease immediate selling pressure. Further up, the next hurdle is located at the 180.00 psychological level, en route to the Bollinger mid-line at 183.82 and the 100-day SMA at 184.70.

On the flip side, the November 10, 2025 low of 177.17 acts as an initial suppot level for the cross. Any follow-through selling below this level could pave the way to the November 4, 2025 low of 176.09, followed by the October 21 low, 2025 of 175.35.

(The technical analysis of this story was written with the help of an AI tool. Know more.)

Japanese Yen FAQs The Japanese Yen (JPY) is one of the world’s most traded currencies. Its value is broadly determined by the performance of the Japanese economy, but more specifically by the Bank of Japan’s policy, the differential between Japanese and US bond yields, or risk sentiment among traders, among other factors.

One of the Bank of Japan’s mandates is currency control, so its moves are key for the Yen. The BoJ has directly intervened in currency markets sometimes, generally to lower the value of the Yen, although it refrains from doing it often due to political concerns of its main trading partners. The BoJ ultra-loose monetary policy between 2013 and 2024 caused the Yen to depreciate against its main currency peers due to an increasing policy divergence between the Bank of Japan and other main central banks. More recently, the gradually unwinding of this ultra-loose policy has given some support to the Yen.

Over the last decade, the BoJ’s stance of sticking to ultra-loose monetary policy has led to a widening policy divergence with other central banks, particularly with the US Federal Reserve. This supported a widening of the differential between the 10-year US and Japanese bonds, which favored the US Dollar against the Japanese Yen. The BoJ decision in 2024 to gradually abandon the ultra-loose policy, coupled with interest-rate cuts in other major central banks, is narrowing this differential.

The Japanese Yen is often seen as a safe-haven investment. This means that in times of market stress, investors are more likely to put their money in the Japanese currency due to its supposed reliability and stability. Turbulent times are likely to strengthen the Yen’s value against other currencies seen as more risky to invest in.

LayerZero Labs, the team behind one of crypto’s most widely used cross-chain messaging protocols, has secured both SOC 2 Type 1 and Type 2 accreditations covering its entire infrastructure. The certification, verified through independent auditing under AICPA Trust Services Criteria, signals that LayerZero’s internal controls around data security, availability, and confidentiality aren’t just well-designed on paper but have actually held up over an extended observation period.

What SOC 2 actually means (and why most crypto projects don’t have it) SOC 2 is an auditing framework created by the American Institute of Certified Public Accountants. It evaluates whether a company’s systems are designed to keep customer data secure, available, and confidential.

The difference between Type 1 and Type 2 matters. Type 1 is a snapshot: an auditor checks whether your controls are properly designed at a single point in time. Type 2 is the harder test, requiring those controls to demonstrate operational effectiveness over a period of three to twelve months. Getting both means LayerZero had to prove its security posture wasn’t just a good idea on a whiteboard but a living, breathing system that worked consistently.

The institutional chess game LayerZero operates a cross-chain messaging protocol that connects more than 160 blockchains, enabling the transfer of stablecoins, tokenized assets, and arbitrary data between otherwise siloed networks.

LayerZero has already built relationships with some heavy hitters. Its partnership roster includes Citadel Securities, DTCC (the entity that settles most US securities trades), ICE (the parent company of the New York Stock Exchange), Google Cloud, and ARK Invest. The SOC 2 certification effectively removes one more objection from institutional due diligence checklists.

The timing also aligns with LayerZero’s planned launch of the Zero blockchain, scheduled for February 2026. That chain is being built for high-throughput institutional use cases, essentially a purpose-built environment where enterprises can leverage LayerZero’s cross-chain capabilities with the compliance guarantees they require.

The accreditation was noted on CertiK Skynet, the security-focused monitoring platform, which tracks compliance milestones alongside smart contract audits and on-chain security events. That it surfaced through compliance tracking channels rather than splashy media announcements is itself telling.

ZRO, LayerZero’s native token, stands to benefit indirectly from these developments. Token value in infrastructure protocols tends to correlate with network usage, and if the SOC 2 certification helps unlock new institutional volumes flowing through LayerZero’s messaging layer, the economic activity feeding into ZRO’s tokenomics grows accordingly.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

3 Unique AI Software Plays With Strong Analyst SupportBraze NASDAQ: BRZE reported fiscal second-quarter 2027 revenue of $227 million, up 26% from a year earlier and 8% sequentially, as the customer-engagement software company cited contract expansions, renewals and new business. The company also raised its revenue outlook for the third quarter and full fiscal year and increased its full-year operating income guidance.

Co-Founder and Chief Executive Officer Bill Magnuson said the quarter featured strong bookings, competitive wins against legacy marketing clouds and point solutions, and continued vendor-consolidation activity. He also pointed to rising customer adoption of the company’s artificial intelligence products and an expanding channel-partner strategy.

Get Braze alerts:

Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance“Brands are adopting ever more sophisticated strategies and racing to deploy AI-driven solutions to leverage their first-party data and direct-to-consumer relationships,” Magnuson said.

Customer growth and retention Total customer count rose 15% year over year to 2,789 as of July 31, 2026, an increase of 367 customers from the prior-year period and 76 from the preceding quarter. The number of customers spending at least $500,000 annually increased 28% year over year to 361. Those larger customers accounted for 65% of annual recurring revenue, compared with 62% a year earlier.

Braze Stock Rallies as Revenue Beats, Buybacks Begin, and Outlook JumpsTrailing 12-month dollar-based net retention was 110% across all customers. For customers spending at least $500,000 annually, net retention rose to 112% from 111% in the prior quarter.

Magnuson said new business and expansions during the quarter included Boots Thailand, Chime, David Jones, Foxtel Group, Insurify, Omaze UK, Property Finder and Wilson Sporting Goods. He said the company also won customers moving from legacy platforms, including a global quick-service restaurant, an Asia-Pacific bank, a European retailer and a U.S. challenger bank.

Remaining performance obligations totaled $1.1 billion, up 27% year over year, while current remaining performance obligations increased 24% to $691 million. Magnuson told analysts that the company’s fourth and first fiscal quarters are typically its largest renewal periods and that current RPO comparisons also reflected lapping the OfferFit acquisition.

AI adoption and product strategy Braze said paid adoption of its AI tools—including Decisioning Studio, Agent Console, AI Item Recommendations and its Predictive Suite—reached roughly one-third of its large-customer cohort during the quarter. That represented an increase of about 900 basis points from the first quarter.

Magnuson said AI monetization remains early, but enterprise customers are seeing returns from the tools. He highlighted Operator, an AI product designed to help marketers create and manage campaigns and workflows, as a driver of adoption of other Braze features.

During the past 90 days, nearly 80% of Braze accounts engaged with Operator more than 10 times, according to Magnuson. More than half of those accounts used it more than 100 times over the same period. He said the product has also reduced customer-support tickets, allowing support staff to focus on more complex issues.

The company said its AI products can support more sophisticated multichannel campaigns, experimentation and personalization. Magnuson said customers that use three, four or five channels and adopt more advanced Braze features historically have shown higher dollar-based net retention than other cohorts.

Braze also introduced Agentic Standards in beta, which allows teams to encode brand guidelines, compliance rules, tracking requirements and content standards for automated checks. The company said it expects to discuss additional developments involving Operator, Content Optimizer, Agent Console and Decisioning Studio at its Forge customer conference.

Magnuson said Decisioning Studio maintained the pricing power discussed when Braze acquired OfferFit, with use-case pricing in the roughly $250,000 to $300,000 range. The company is also developing Decisioning Studio Go, a more self-service offering that will be paid for through Action Credits and have a lower upfront cost than Decisioning Studio Pro.

Profitability, cash flow and capital returns Subscription revenue represented 91% of total second-quarter revenue, while the remaining 9% came from recurring professional services and one-time configuration and onboarding fees. Interim Chief Financial Officer Pankaj Malik said approximately 90% of professional-services revenue is recurring and recognized ratably over the related contract term.

Malik said the company has been shifting some customer-success entitlements that were previously bundled in subscription fees into professional-services arrangements under its newer pricing and packaging structure. Braze has migrated about half of its customer base and expects about 80% of the remaining customers to transition over the next six quarters. He said professional services are expected to represent about 9% to 10% of revenue going forward.

Non-GAAP gross profit was $156 million, with a 68.6% gross margin, compared with 69.3% a year earlier. Non-GAAP operating income was $22 million, or 9.7% of revenue, compared with $6 million, or 3.4% of revenue, in the prior-year quarter. Non-GAAP net income attributable to Braze shareholders was $21 million, or $0.19 per share, compared with $17 million, or $0.15 per share, a year earlier. Cash provided by operations was $24 million, and free cash flow was $22 million, compared with $4 million in the prior-year quarter. Braze ended the quarter with approximately $414 million in cash equivalents, restricted cash and marketable securities. In August, it completed a $50 million accelerated share repurchase program, buying back approximately 2.1 million shares. Another $50 million remains under the board’s authorization.

Raised outlook and AWS partnership For the fiscal third quarter, Braze expects revenue of $229 million to $230 million, representing roughly 20% year-over-year growth at the midpoint. It forecast non-GAAP operating income of $16 million to $17 million, or about a 7% operating margin, and non-GAAP earnings per share of $0.13 to $0.14.

For fiscal 2027, the company now expects revenue of $910 million to $913 million, representing approximately 23% growth at the midpoint. It projected non-GAAP operating income of $75.5 million to $76.5 million, implying an 8% operating margin, and non-GAAP earnings per share of $0.64 to $0.65.

Malik said third-quarter operating income will be affected by the costs of Forge and other global customer events, while Magnuson said the company is also beginning to add sales capacity ahead of the next fiscal year.

Braze additionally announced a three-year strategic collaboration agreement with Amazon Web Services. Magnuson said the agreement establishes a dedicated co-selling motion, joint go-to-market commitments and incentives for AWS sellers to bring Braze into customer accounts. He said the arrangement builds on rising procurement through AWS Marketplace and could extend Braze’s international and industry reach.

About Braze (NASDAQ:BRZE)Braze, Inc is a publicly traded software company NASDAQ: BRZE that offers a customer engagement platform designed to help brands build personalized relationships with their users. Founded in 2011 as Appboy by Bill Magnuson, Jon Hyman and Mark Ghermezian, the company adopted the Braze name in 2017 to underscore its focus on fostering strong connections between businesses and consumers. Its cloud-based platform consolidates messaging channels including push notifications, in-app messages, email and SMS, enabling companies to deliver timely, context-driven communications at scale.

The core functionality of Braze's platform centers on data-driven segmentation, customer journey orchestration and real-time analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Braze Right Now?Before you consider Braze, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braze wasn't on the list.

While Braze currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Key Takeaways Boston Scientific cut 2026 growth expectations as WATCHMAN and EP face mounting U.S. pressure.Boston Scientific expects 2027 growth to stay muted before new catalysts could lift results in 2028.Boston Scientific lost 55.8% over 12 months, while its 14.13 forward P/E trails historical and industry norms. Boston Scientific (BSX - Free Report) has entered the second half of 2026 with more pressure than expected as weakness in two important businesses weighs on its near-term performance. WATCHMAN has been hurt by a sharp slowdown in the U.S. market, with clinical evidence affecting referral patterns. In Electrophysiology (“EP”), the company is facing greater competitive share losses in the United States than expected. Together, these headwinds are making it more challenging for the company to deliver the growth it has historically achieved.

Boston Scientific lowered its 2026 expectations, now calling for organic revenue growth of 5% to 6% and adjusted earnings per share (EPS) of $3.28 to $3.32, or 7% to 8% growth. Management expects the pressure to extend into 2027, when revenue growth could remain below its weighted average market growth rate and adjusted EPS growth may be limited.

On a positive note, growth could pick up meaningfully in 2028, as new catalysts begin to take effect. Based on investments made over the past two or three years, the company will have seven new launches that surpass nearly $25 billion in total addressable market (TAM). Among them are the planned launch of the SEISMIQ 4CE Coronary IVL Catheter in the first half of 2027 after positive FRACTURE trial data and the introduction of the FARAWAVE Ultra mapping and ablation catheter. The pending Penumbra acquisition could also strengthen Boston Scientific’s long-term growth profile.

The company is pursuing a restructuring program targeting approximately $500 million in annual run-rate savings by the end of 2029, with more than half expected by the end of 2027. The savings will be focused in the areas of supply-chain optimization, targeted functional changes, organizational restructuring and reductions in indirect spending, supporting operating-margin expansion and stronger adjusted EPS growth in 2028 and beyond.

Latest Developments Among BSX’s PeersAbbott (ABT - Free Report) recently presented new late-breaking 12-month data from the FlexPulse Global IDE study, showing favorable safety and effectiveness outcomes for the company’s investigational TactiFlex Duo Ablation Catheter, Sensor Enabled to treat patients with challenging cases of atrial fibrillation. Abbott’s Nutrition business also launched Similac 360 Total Care Made With Whole Milk, the only commercially sterile, ready-to-feed liquid infant formula made with whole milk in the United States.

Globus Medical’s (GMED - Free Report) Excelsius3D intelligent 3-in-1 imaging system achieved the CE mark for commercial sale in the European Union and the United Kingdom. The system received FDA’s 510(k) clearance in 2021. The addition of Excelsius3D expands the company’s Excelsius Ecosystem of enabling technologies and enhances the capabilities of the ExcelsiusGPS robotic navigation system in the European Union. Globus Medical also announced the acquisition of Higgs Boson Health, a Duke University-incubated digital healthcare company based in Durham, NC.

BSX’s Price Performance, Valuation and EstimatesOver the past 12 months, Boston Scientific shares have plunged 55.8% compared with the industry’s 27.1% decline. 

Image Source: Zacks Investment Research

Boston Scientific trades at a forward earnings multiple of 14.13 over the past 12 months, lower than its historical median and industry average. 

Image Source: Zacks Investment Research

The company’s earnings estimates have trended lower over the past three months.

Image Source: Zacks Investment Research

BSX stock currently carries a Zacks Rank #5 (Strong Sell).  

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

IonQ IONQ shares jumped 5% on Tuesday as the quantum computing company raised its 2026 revenue forecast following the integration of SkyWater Technologies.

IonQ now projects 2026 revenue of $450 million to $460 million, with the range including revenue from SkyWater. IonQ completed the acquisition on July 31, giving the company access to SkyWater's semiconductor manufacturing capabilities.

The company also released research detailing the resources required to run Shor's algorithm on a fault-tolerant quantum system. The work examines how applications can be adapted for trapped-ion quantum computers.

IonQ separately introduced Superion 256, its sixth-generation quantum platform. The chips were manufactured at SkyWater and are available for customer orders, with deliveries expected next year.

The updates give investors several areas to watch as IonQ combines its quantum technology with SkyWater's manufacturing operations. The higher revenue forecast also provides a new financial benchmark following the acquisition.

The raised outlook and product launch could support investor sentiment as the combined business moves toward commercial deliveries.

Hsbc Holdings PLC grew its position in shares of ResMed Inc. (NYSE:RMD – Free Report) by 13.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 355,518 shares of the medical equipment provider’s stock after buying an additional 42,007 shares during the period. Hsbc Holdings PLC owned about 0.25% of ResMed worth $69,292,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. International Assets Investment Management LLC bought a new position in ResMed during the fourth quarter worth $25,000. Bell Investment Advisors Inc acquired a new position in ResMed in the second quarter worth $26,000. Imprint Wealth LLC bought a new stake in ResMed during the third quarter valued at $26,000. WFA of San Diego LLC bought a new stake in ResMed during the second quarter valued at $26,000. Finally, Sunbelt Securities Inc. acquired a new stake in shares of ResMed during the third quarter worth $31,000. Institutional investors and hedge funds own 54.98% of the company’s stock.

ResMed Stock Performance RMD stock opened at $228.25 on Tuesday. ResMed Inc. has a 1 year low of $180.26 and a 1 year high of $284.87. The stock has a market capitalization of $32.93 billion, a price-to-earnings ratio of 21.88, a PEG ratio of 1.44 and a beta of 0.77. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.42 and a current ratio of 3.10. The stock’s fifty day moving average is $216.10 and its two-hundred day moving average is $217.79.

ResMed (NYSE:RMD – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The medical equipment provider reported $2.95 EPS for the quarter, topping the consensus estimate of $2.89 by $0.06. ResMed had a net margin of 26.94% and a return on equity of 25.58%. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.46 billion. During the same quarter in the prior year, the firm earned $2.55 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. On average, research analysts predict that ResMed Inc. will post 12.02 EPS for the current year. ResMed Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, August 20th will be given a $0.66 dividend. This is a positive change from ResMed’s previous quarterly dividend of $0.60. The ex-dividend date is Thursday, August 20th. This represents a $2.64 annualized dividend and a yield of 1.2%. ResMed’s payout ratio is currently 25.31%.

Insider Activity In other ResMed news, Director Peter Farrell sold 8,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $225.00, for a total value of $1,800,000.00. Following the sale, the director owned 52,773 shares in the company, valued at approximately $11,873,925. This trade represents a 13.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Michael Farrell sold 4,991 shares of ResMed stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $218.55, for a total value of $1,090,783.05. Following the sale, the chief executive officer directly owned 466,223 shares in the company, valued at approximately $101,893,036.65. This trade represents a 1.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 18,952 shares of company stock valued at $4,145,070. 0.65% of the stock is owned by insiders.

Wall Street Analyst Weigh In A number of research analysts have recently issued reports on the stock. Morgan Stanley restated an “equal weight” rating and issued a $230.00 price target (down from $286.00) on shares of ResMed in a research report on Wednesday, June 17th. Wells Fargo & Company lowered their price objective on shares of ResMed from $225.00 to $215.00 and set an “equal weight” rating for the company in a research report on Friday, August 7th. The Goldman Sachs Group reiterated a “buy” rating on shares of ResMed in a research note on Wednesday, July 1st. Rothschild & Co Redburn began coverage on shares of ResMed in a report on Wednesday, August 19th. They issued a “neutral” rating and a $230.00 target price on the stock. Finally, UBS Group restated a “buy” rating and issued a $300.00 target price on shares of ResMed in a research note on Tuesday, July 21st. Six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, ResMed presently has a consensus rating of “Hold” and a consensus target price of $240.31.

View Our Latest Stock Analysis on ResMed

ResMed Company Profile (Free Report)

ResMed (NYSE: RMD) is a global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. Founded in 1989, the company is headquartered in San Diego, California, and develops, manufactures and distributes a range of devices and software used by patients, clinicians and providers worldwide.

ResMed’s product portfolio centers on noninvasive ventilation and sleep therapy equipment, including continuous positive airway pressure (CPAP) and bilevel devices, masks and related accessories for the treatment of obstructive sleep apnea and other respiratory disorders.

See Also Five stocks we like better than ResMed 3 Under-the-Radar Defense Stocks With Record Backlogs This Korea ETF Has Soared, But the Rally May Not Be Over Why Guidewire’s Post-Earnings Plunge May Not Last Ride-Share Reckoning: Tesla Drives Into Uber’s Lane

Receive News & Ratings for ResMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ResMed and related companies with MarketBeat.com's FREE daily email newsletter.

MALTA, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (Nasdaq: GFS) (GF) today announced it has finalized a definitive agreement with the U.S. Department of Commerce’s CHIPS Research and Development Office for a $375 million award for research and development to accelerate the company's Quantum Technology Solutions (QTS) business, designed to help scale domestic quantum semiconductor manufacturing and strengthen the United States' leadership in quantum technologies.

The agreement advances the goal of establishing a secure, U.S.-based ecosystem for the development and manufacturing of quantum chips. Through Quantum Technology Solutions, GF is accelerating R&D and expanding access to advanced manufacturing capabilities and enabling quantum computing companies to move from research and prototyping toward commercial-scale production. Under the agreement, GF is eligible to receive up to $375 million in funding over a five-year period tied to the achievement of specified milestones.

"This is another important milestone for Quantum Technology Solutions and our efforts to build a scalable domestic quantum manufacturing ecosystem," said Nicholas Sergeant, vice president and general manager of Quantum Technology Solutions at GlobalFoundries. "Since launching, we have expanded engagement with customers and ecosystem partners who are leveraging GF's R&D and manufacturing expertise to address some of the industry's most challenging scaling requirements. We're grateful for the Department of Commerce's support as we continue building the foundation for a secure, domestic quantum manufacturing ecosystem."

GF has continued to advance its quantum technology roadmap and deepen collaborations across the quantum ecosystem. The company's efforts are focused on enabling the transition from research-driven innovation to scalable manufacturing through differentiated capabilities in cryogenic CMOS technologies, advanced packaging and heterogeneous integration, helping position GF as a foundry partner of choice for emerging quantum applications.

The completion of the agreement reflects continued progress toward establishing a robust U.S. quantum supply chain and expands GF's broader efforts to advance critical semiconductor technologies. GF has also recently announced it has entered into a $300 million letter of intent with the Department's CHIPS Research and Development Office to accelerate R&D in silicon photonics. GF’s initiatives in quantum computing and next-generation optical connectivity are two technologies expected to be foundational to future AI infrastructure and advanced computing systems. GF is focused on continuing to strengthen its position as a trusted manufacturing partner for emerging technology innovators through investments in research.

About GF
GlobalFoundries (GF) is a leading manufacturer of essential semiconductors, enabling AI at scale from the cloud to the physical world. Through deep partnerships with customers, GF delivers differentiated, power efficient and high performance solutions for automotive, aerospace and defense, data center, smart mobile devices, internet of things and other high growth markets. With global manufacturing operations across the U.S., Europe and Asia, GF is a trusted and holistic technology partner for customers around the world. GF’s talented, global team remains focused every day on security, longevity and sustainability. For more information, visit www.gf.com.

Forward-Looking Statements
This press release includes “forward-looking statements” that reflect our current expectations and views of future events. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995 and include but are not limited to, statements regarding our financial outlook, future guidance, product development, business strategy and plans, and market trends, opportunities and positioning. These statements are based on current expectations, assumptions, estimates, forecasts, projections and limited information available at the time they are made. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall,” "outlook," "on track" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to a broad variety of risks and uncertainties, both known and unknown. Any inaccuracy in our assumptions and estimates could affect the realization of the expectations or forecasts in these forward-looking statements. For example, our business could be impacted by geopolitical conditions such as the ongoing political and trade tensions with China and the continuation of conflicts in the Middle East and Ukraine; ongoing political developments in the United States, and in particular, any political and policy-related changes that may impact our industry and the market generally, such as the imposition of trade controls, tariffs and counter-tariffs between the United States and its trade partners and new legislation; the market for our products may develop or recover more slowly than expected or than it has in the past; we may fail to achieve the full benefits of our strategic optimization efforts; our operating results may fluctuate more than expected; there may be significant fluctuations in our results of operations and cash flows related to our revenue recognition or otherwise; a network or data security incident that allows unauthorized access to our network or data or our customers’ data could result in a system disruption, loss of data or damage our reputation; we could experience interruptions or performance problems associated with our technology, including a service outage; global economic conditions could deteriorate, including due to rising inflation and any potential recession; the expected benefits of our announced partnerships may fail to materialize; and we may fail to achieve the anticipated results or benefits from funding received (including awards under the U.S. CHIPS and Science Act and New York State Green CHIPS) and our expected results and planned or further expansions and operations may not proceed as planned if funding we expect to receive is delayed or withheld for any reason. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results or outcomes to differ materially from those contained in any forward-looking statements we may make. Moreover, we operate in a competitive and rapidly changing market, and new risks may emerge from time to time. You should not rely upon forward-looking statements as predictions of future events. These statements are based on our historical performance and on our current plans, estimates and projections in light of information currently available to us, and therefore you should not place undue reliance on them.

Although we believe that the expectations reflected in our statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. Moreover, neither we, nor any other person, assumes responsibility for the accuracy and completeness of these statements. Recipients are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date such statements are made and should not be construed as statements of fact. Except to the extent required by federal securities laws, we undertake no obligation to update any information or any forward-looking statements as a result of new information, subsequent events or any other circumstances after the date hereof, or to reflect the occurrence of unanticipated events. For a discussion of potential risks and uncertainties, please refer to the risk factors and cautionary statements in our 2025 Annual Report on Form 20-F, current reports on Form 6-K and other reports filed with the Securities and Exchange Commission (SEC). Copies of our SEC filings are available on our Investor Relations website, investors.gf.com, or from the SEC website, www.sec.gov.

Abraxas Capital has bought another 13,000 ETH worth $32.39 million in the spot market to hedge part of a 141,180 ETH short position on Hyperliquid valued at $353.27 million.

Summary

Abraxas Capital bought another 13,000 ETH worth $32.39 million in the spot market, according to Lookonchain. The purchase was made to hedge a 141,180 ETH short position on Hyperliquid valued at $353.27 million. The latest spot purchase covers just over 9% of the short when measured by the number of ETH. Abraxas previously accumulated more than 211,000 ETH worth over $477 million during a six day buying run in May 2025. Lookonchain said on Sept. 8 that Abraxas Capital purchased the additional Ether while keeping its much larger short position open on the decentralized derivatives platform. The blockchain analytics account described the transaction as another spot purchase made specifically to hedge the short.

At the values provided by Lookonchain, the latest purchase was made at an implied price of roughly $2,491 per ETH. The 13,000 ETH position equals just over 9% of the firm’s 141,180 ETH short when measured by the number of tokens.

Abraxas therefore remains heavily net short based solely on the positions disclosed by Lookonchain. Subtracting the latest 13,000 ETH spot hedge from the 141,180 ETH short leaves 128,180 ETH of net short exposure before considering any other holdings or positions controlled by the firm.

Abraxas Capital keeps $353 million ETH short open Lookonchain valued the Hyperliquid short at approximately $353.27 million at the time of its post, compared with $32.39 million for the latest spot purchase.

The hedge gives Abraxas exposure to ETH in opposite directions. The short position benefits from a decline in Ether’s price, while the spot ETH gains value when the token rises. Lookonchain specifically characterized the latest purchase as a hedge, rather than a closure or reduction of the underlying short position.

Large leveraged positions have become common on Hyperliquid, where whale accounts have carried several billion dollars in combined positions this year.

In May, crypto.news previously reported that Hyperliquid whale positions had reached $4.039 billion. Long exposure stood at $1.981 billion, while shorts accounted for $2.058 billion, producing a long-to-short ratio of 0.96.

Both sides of the whale book were underwater at the time. Long positions carried roughly $30.8 million in aggregate unrealized losses, compared with approximately $14.6 million in losses on short positions.

One of the largest individual trades in the May snapshot involved an ETH whale using 15x leverage. The account held roughly $87 million in Ether exposure from an entry near $2,265 and was sitting on more than $3.6 million in unrealized losses.

A separate reading five days earlier placed Hyperliquid whale exposure at $4.236 billion. Long positions totaled $2.099 billion, or 49.55% of the total, against $2.137 billion in shorts.

The split produced a long-to-short ratio of 0.98, leaving large traders almost evenly positioned between bullish and bearish bets.

Abraxas has made large Ethereum purchases before The latest transaction is not Abraxas Capital’s first large on-chain move involving Ether.

In May 2025, the investment manager withdrew 138,511 ETH valued at roughly $297 million from centralized exchanges over two days, according to Lookonchain. The transfers occurred during a sharp ETH rally that pushed the token above $2,300.

Abraxas then increased its holdings with another 33,482 ETH purchase worth $84.7 million.

Lookonchain data cited at the time showed that the firm had accumulated 211,030 ETH over six days, worth more than $477 million. The purchases followed the earlier withdrawal of approximately $297 million in ETH from exchanges.

The 2025 accumulation occurred under different market conditions and does not establish the purpose of the firm’s current positions. Lookonchain has specifically described the Sept. 8 spot transaction as a hedge against the Hyperliquid short.

Hyperliquid whale positioning has changed considerably at different points this year. In April, large trader positions totaled $3.4 billion, consisting of $1.737 billion in longs and $1.663 billion in shorts.

Long positions were carrying approximately $153 million in aggregate unrealized losses at the time, while shorts were sitting on roughly $161 million in unrealized profits.

An ETH whale tracked in the same dataset held a 15x leveraged long from around $2,148.70 and was down approximately $8.6 million.

Ethereum trades close to $2,500 Abraxas made its latest hedge while Ether remained close to the $2,500 level following a recovery from early September lows.

On Sept. 7, Ethereum traded near $2,493 after moving between approximately $2,475 and $2,537 during the session.

ETH had repeatedly failed to hold above $2,500, while its daily relative strength index had eased to 63.62 after the August rally.

Liquidation data cited in the report showed notable leveraged positions clustered around $2,430 below the market and between $2,540 and $2,600 above it. The nearest support zone was concentrated between roughly $2,423 and $2,475.

Ether had been trading considerably lower less than a week earlier. On Sept. 2, the token fell to an intraday low of $2,356 after failing to clear resistance close to $2,550.

Approximately $94.2 million in ETH futures positions were liquidated over 24 hours during the decline, while Ethereum fell below $2,400.

ETH remained above several medium-term moving averages at the time, including its 20-day simple moving average near $2,299 and its 50-day, 100-day and 200-day averages near $2,054, $1,903 and $2,030, respectively.

The token later recovered toward the $2,500 area, putting Abraxas’ latest 13,000 ETH spot purchase close to the same price zone.

Institutional demand for spot Ether has remained active during the recovery. U.S. spot Ethereum exchange-traded funds recorded $225.8 million in net inflows on Aug. 28, extending a nine-session buying streak to $1.42 billion.

BlackRock’s ETHA accounted for $1.02 billion, or roughly 72%, of the nine-day ETF inflows. Fidelity’s FETH recorded $56.2 million on Aug. 28, while BlackRock’s staked ETHB product added $20.7 million.

Lookonchain’s Sept. 8 figures put Abraxas Capital’s latest spot hedge at 13,000 ETH worth $32.39 million, while the firm’s Hyperliquid short remained at 141,180 ETH with a notional value of $353.27 million.